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ABSTRACT	   	   	   1	  
	   Herpes	  Simplex	  Virus	  type	  1	  (HSV-­‐1)	  infects	  nearly	  60%	  of	  the	  U.S.	  population,	  and	  is	  a	  
significant	  cause	  of	  viral	  encephalitis	  and	  neuroinflammatory	  diseases.	  	  HSV-­‐1	  actively	  replicates	  
in	  stratified	  epithelia,	  and	  then	  migrates	  to	  sensory	  neurons	  where	  it	  establishes	  a	  life-­‐long,	  
latent	  infection.	  	  It	  was	  recently	  demonstrated	  that	  HSV-­‐1	  can	  suppress	  exogenous	  RNA	  
silencing,	  and	  viral	  replication	  is	  enhanced	  in	  the	  absence	  of	  Ago2.	  	  I	  investigated	  this	  further	  in	  
a	  physiologically	  relevant	  in	  vitro	  epidermal	  cell	  culture	  model	  to	  determine	  if	  suppression	  of	  
RNAi	  pathway	  components	  had	  any	  effect	  on	  HSV-­‐1	  replication,	  and	  if	  HSV-­‐1	  modulated	  
endogenous	  miRNA	  silencing	  and	  expression.	  	  I	  found	  that	  deletion	  of	  Ago2	  enhanced	  HSV-­‐1	  
viral	  titers	  two	  to	  six-­‐fold,	  and	  that	  the	  virus	  is	  capable	  of	  suppressing	  expression	  of	  mature	  
miRNAs	  as	  well	  as	  their	  silencing	  function.	  	  These	  findings	  contribute	  to	  the	  nascent	  body	  of	  
literature	  examining	  antiviral	  RNAi	  functions	  in	  mammals,	  and	  further	  our	  understanding	  of	  the	  
epidermal	  response	  to	  one	  of	  the	  most	  common	  viral	  infections	  in	  the	  U.S.	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EPIDERMAL	  IMMUNITY	  
	   The	  epidermis	  is	  one	  of	  the	  most	  immunogenic	  organs	  in	  the	  body.	  	  Large	  numbers	  of	  
hematopoietic-­‐derived	  cells	  populate	  the	  skin,	  including	  20	  billion	  T	  cells	  residing	  in	  the	  human	  
epidermis	  (Clark	  et	  al.	  2006).	  	  Numerous	  other	  cell	  types,	  of	  both	  myeloid	  and	  lymphoid	  
lineages,	  make	  up	  the	  remaining	  epidermal	  resident	  immune	  cell	  population.	  	  The	  skin,	  along	  
with	  other	  forms	  of	  stratified	  epithelia,	  forms	  the	  primary	  barrier	  to	  microbial	  infections.	  	  
Keratinocytes,	  the	  cell	  type	  that	  makes	  up	  the	  epidermis,	  secrete	  anti-­‐microbial	  peptides	  and	  
express	  immune	  surveillance	  molecules.	  	  In	  addition	  to	  the	  sensing	  carried	  out	  by	  immune	  
sentinels,	  keratinocytes	  play	  a	  major	  role	  in	  activating	  and	  promoting	  inflammatory	  responses.	  
	   Epidermal	  immune	  responses	  are	  critical	  for	  combating	  many	  bacterial	  infections,	  as	  
well	  as	  extremely	  common	  viral	  infections	  such	  as	  Herpes	  Simplex	  Virus	  type	  1	  (HSV-­‐1)	  and	  
Human	  Papillomavirus	  (HPV).	  	  HPV	  infects	  many	  types	  of	  stratified	  epithelium,	  including	  the	  
epidermis,	  and	  is	  a	  major	  cause	  of	  cervical	  cancers	  (Vandermark	  et	  al.	  2012).	  	  HSV-­‐1	  carries	  out	  
its	  lytic	  infection	  cycle	  in	  keratinocytes,	  which	  serve	  as	  the	  exclusive	  environment	  for	  HSV-­‐1	  viral	  
production.	  	  Despite	  the	  number	  of	  human	  diseases	  involving	  immune	  responses	  in	  the	  skin,	  
very	  little	  is	  known	  about	  how	  keratinocytes	  function	  to	  mount	  an	  effective	  adaptive	  response.	  
	   The	  skin	  is	  a	  highly	  organized	  tissue,	  composed	  primarily	  of	  keratinocytes	  in	  stratified	  
layers	  of	  sequential	  differentiation	  states	  (Figure	  1).	  	  Throughout	  the	  life	  of	  an	  organism,	  skin	  is	  
constantly	  shed	  and	  regenerated,	  and	  therefore	  has	  a	  remarkable	  capacity	  for	  self-­‐renewal	  and	  
regulation	  of	  homeostasis.	  	  The	  mesenchymal-­‐epithelial	  junction	  is	  defined	  by	  the	  basement	  
membrane,	  to	  which	  basal	  keratinocytes	  are	  attached.	  	  Basal	  keratinocytes	  make	  up	  the	  
interfollicular	  epidermal	  stem	  cell	  population,	  and	  are	  characterized	  by	  the	  expression	  of	  
keratins	  5	  and	  14	  (Blanpain	  and	  Fuchs	  2009).	  	  These	  cells	  undergo	  asymmetric	  cell	  division	  to	  
form	  the	  suprabasal	  layer,	  marked	  by	  keratin	  10	  and	  loricrin	  expression	  (Lechler	  and	  Fuchs	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2005).	  	  Suprabasal	  cells	  have	  permanently	  exited	  the	  cell	  cycle,	  but	  are	  still	  capable	  of	  
performing	  metabolic	  processes.	  	  Beyond	  the	  suprabasal	  layer,	  keratinocytes	  begin	  to	  cornify	  
and	  form	  the	  granular	  and	  stratum	  corneal	  layers	  of	  the	  epidermis.	  	  These	  tough,	  cornified	  
layers	  function	  as	  a	  barrier,	  protecting	  the	  organism	  from	  microbes	  and	  other	  environmental	  
hazards.	  
	   Keratinocytes	  form	  the	  organism’s	  primary	  barrier	  against	  microbial	  infection,	  and	  
therefore	  are	  highly	  equipped	  to	  detect	  the	  presence	  of	  microbes.	  	  This	  is	  carried	  out	  at	  the	  
cellular	  level	  through	  a	  class	  of	  molecules	  known	  as	  pattern	  recognition	  receptors	  (PRRs).	  	  These	  
protein	  complexes	  are	  located	  on	  the	  plasma	  membrane,	  in	  the	  endosome,	  or	  occasionally	  in	  
the	  cytosol,	  and	  serve	  to	  detect	  the	  presence	  of	  viruses,	  bacteria,	  and	  parasites.	  	  PRRs	  recognize	  
molecular	  signatures	  specific	  to	  pathogens,	  termed	  pathogen-­‐associated	  molecular	  patterns	  
(PAMPs).	  	  These	  molecular	  signatures	  are	  motifs	  that	  are	  not	  found	  on	  the	  organism’s	  host	  cells,	  
and	  therefore	  signify	  the	  presence	  of	  a	  microbe.	  	  Some	  of	  these	  signatures	  include	  double-­‐
stranded	  RNA	  (dsRNA),	  a	  hallmark	  of	  RNA	  virus	  infection;	  lipopolysaccharide,	  a	  component	  of	  
	  
Figure	  1.	  The	  epidermis	  is	  a	  form	  of	  stratified	  epithelium.	  	  It	  is	  comprised	  of	  distinct	  layers	  that	  undergo	  
serial	  differentiation	  programs	  to	  produce	  the	  cornified	  outer	  layer	  that	  serves	  the	  barrier	  function.	  	  The	  
skin	  is	  maintained	  by	  a	  population	  of	  progenitor	  stem	  cells,	  known	  as	  basal	  cells.	  	  They	  are	  committed	  to	  
the	  epidermal	  lineage	  and	  reside	  in	  the	  layer	  adjacent	  to	  the	  basement	  membrane.	  	  They	  self-­‐renew	  by	  
undergoing	  symmetric	  divisions.	  	  Asymmetric	  divisions	  give	  rise	  to	  the	  suprabasal	  later.	  	  Suprabasal	  cells	  
remain	  metabolically	  active,	  but	  have	  permanently	  exited	  the	  cell	  cycle.	  	  Hair	  follicles	  perforate	  the	  
epidermis.	  	  The	  hair	  germ	  extends	  down	  into	  the	  dermis.	  	  Distinct	  populations	  of	  hair	  follicle	  stem	  cells	  
undergo	  differentiation	  to	  form	  each	  layer	  of	  the	  hair	  shaft.	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gram-­‐negative	  bacterial	  membranes;	  flagellin	  and	  peptidoglycan,	  other	  components	  of	  bacterial	  
membranes;	  and	  CpG-­‐unmethylated	  DNA,	  which	  is	  found	  in	  viruses	  and	  bacteria,	  but	  not	  
eukaryotes.	  	  Signaling	  through	  these	  receptors	  is	  triggered	  by	  ligand	  binding,	  and	  leads	  to	  
activation	  of	  pro-­‐inflammatory	  transcription	  factors,	  including	  NF-­‐κB,	  NFAT,	  and	  AP-­‐1	  (c-­‐Jun-­‐Fos	  
heterodimer).	  	  These	  proteins	  induce	  transcription	  of	  pro-­‐inflammatory	  cytokines	  and	  
chemokines,	  as	  well	  as	  interferons	  (IFNs)	  in	  the	  case	  of	  viral	  infection.	  	  PRRs	  are	  critical	  for	  not	  
only	  detecting	  the	  presence	  of	  an	  infection,	  but	  also	  assisting	  the	  immune	  system	  in	  fine-­‐tuning	  
its	  response	  to	  the	  specific	  type	  of	  invading	  microbe.	  
	   Numerous	  immune	  cells	  of	  hematopoietic	  lineage	  reside	  within	  the	  interfollicular	  
epidermis	  (IFE).	  	  These	  cells	  include	  dendritic	  cells,	  Langerhans	  cells,	  macrophages,	  and	  T	  cell	  
lineages.	  	  Langerhans	  cells,	  dendritic	  cells,	  and	  macrophages	  are	  descendants	  of	  the	  myeloid	  
lineage,	  whereas	  T	  cell	  populations	  are	  derived	  from	  lymphoid	  progenitors.	  	  Langerhans	  cells	  
(LCs)	  are	  a	  distinct	  subset	  of	  dendritic	  cells,	  found	  primarily	  in	  the	  skin	  and	  other	  forms	  of	  
stratified	  epithelium.	  	  These	  cells	  are	  characterized	  by	  the	  presence	  of	  distinctive	  Birbeck	  
granules	  (Valladeau	  et	  al.	  2000).	  	  LCs	  are	  critical	  for	  immunoregulation	  in	  the	  skin,	  and	  have	  
been	  shown	  to	  have	  both	  pro-­‐	  and	  anti-­‐inflammatory	  properties	  (Kaplan	  et	  al.	  2010;	  Lutz	  et	  al.	  
2010;	  Stoitzner	  2010).	  	  Non-­‐langerin	  expressing	  dendritic	  cells	  (DCs),	  termed	  dermal	  dendritic	  
cells	  (dDCs),	  also	  contribute	  to	  adaptive	  epidermal	  immune	  responses.	  	  They	  are	  professional	  
antigen	  presenting	  cells	  (APCs),	  meaning	  they	  take	  up	  antigen	  from	  the	  surrounding	  tissue	  and	  
present	  it	  to	  naïve	  T	  cells	  on	  MHC	  class	  II	  complexes.	  	  There	  is	  also	  some	  evidence	  that	  dDCs,	  
excluding	  LCs,	  are	  responsible	  for	  priming	  naïve	  CD8+	  T	  cells	  in	  the	  lymphoid	  tissue	  (Allan	  et	  al.	  
2003).	  	  The	  skin	  is	  home	  to	  a	  diverse	  repertoire	  of	  T	  cells,	  including	  CD4+	  and	  CD8+	  effector,	  
memory,	  and	  regulatory	  subtypes	  (Clark	  et	  al.	  2006;	  Seneschal	  et	  al.	  2012;	  Jiang	  et	  al.	  2012).	  	  
These	  cells	  reside	  permanently	  in	  the	  epidermis,	  providing	  long-­‐lasting	  protective	  immunity	  and	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are	  distinct	  from	  their	  lymphatic	  relatives	  (Seneschal	  et	  al.	  2012,	  Jiang	  et	  al.	  2012).	  	  These	  skin-­‐
resident	  immune	  cells	  are	  important	  for	  translating	  intracellular	  innate	  immune	  responses	  in	  
keratinocytes	  to	  an	  effective,	  leukocyte-­‐mediated	  adaptive	  response.	  
Keratinocytes	  also	  assist	  with	  systemic	  immune	  activation	  by	  signaling	  to	  resident	  APCs	  
including	  DCs,	  macrophages,	  and	  epidermal-­‐specific	  LCs.	  	  DCs	  and	  LCs	  make	  up	  the	  dominant	  
population	  of	  APCs	  in	  the	  skin.	  	  Several	  populations	  of	  CD4+	  or	  CD8+	  resident	  memory	  T	  cells	  
(TRM)	  also	  reside	  in	  the	  skin,	  but	  their	  interaction	  with	  keratinocytes	  has	  not	  been	  documented.	  	  
LCs	  are	  an	  important	  bridge	  between	  innate	  and	  adaptive	  immunity	  in	  the	  skin.	  LCs	  physically	  
interact	  with	  neighboring	  keratinocytes	  though	  E-­‐cadherin,	  suggesting	  that	  keratinocytes	  
provide	  a	  niche	  for	  LCs	  (Tang	  et	  al.	  1993).	  	  The	  keratinocyte-­‐generated	  niche	  is	  essential	  for	  
maturation	  of	  LCs,	  as	  they	  develop	  from	  hematopoietic	  precursors	  located	  in	  the	  epidermis,	  
rather	  than	  migrating	  to	  the	  skin	  after	  maturation.	  	  Evidence	  suggests	  that	  growth	  factors	  
essential	  for	  LC	  development,	  such	  as	  TGFβ1	  and	  M-­‐CSF,	  are	  produced	  by	  bulge	  stem	  cells	  in	  the	  
hair	  follicle	  (Merad	  et	  al.	  2008)	  (Figure	  1).	  	  This	  suggests	  that	  the	  bulge	  region	  of	  the	  hair	  follicle	  
may	  provide	  the	  environment	  for	  maturation	  of	  epidermal	  myeloid	  cells,	  but	  this	  has	  not	  yet	  
been	  tested.	  	  In	  addition	  to	  physical	  interactions	  between	  keratinocytes	  and	  LCs,	  there	  is	  also	  
evidence	  that	  keratinocytes	  are	  essential	  for	  LC	  function.	  	  It	  has	  been	  demonstrated	  in	  vitro	  that	  
keratinocytes	  are	  required	  for	  activation	  of	  LCs	  in	  response	  to	  artificial	  stimuli	  (Sugita	  et	  al.	  
2007).	  	  Following	  stimulation	  with	  TLR9	  ligand	  (CpG	  dsDNA),	  only	  LCs	  co-­‐cultured	  with	  
keratinocytes	  or	  treated	  with	  keratinocyte	  cell	  culture	  media	  were	  able	  to	  stimulate	  T	  cell	  
proliferation	  in	  a	  mouse	  model	  (Sugita	  et	  al.	  2007).	  	  Based	  on	  these	  findings,	  keratinocytes	  are	  
clearly	  active	  participants	  in	  the	  epidermal	  immune	  response	  by	  activating	  LCs	  to	  perform	  their	  
antigen-­‐presenting	  functions.	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   The	  epidermis	  is	  well	  established	  to	  serve	  a	  critical	  barrier	  function,	  protecting	  
organisms	  from	  the	  surrounding	  microbe-­‐dominated	  environment.	  	  It	  is	  one	  of	  the	  most	  
immunogenic	  organs	  in	  the	  body,	  containing	  numerous	  types	  of	  myeloid	  and	  lymphoid	  lineages.	  	  
However,	  there	  is	  no	  consensus	  regarding	  the	  role	  of	  keratinocytes	  in	  the	  epidermal	  immune	  
response.	  	  A	  thorough	  investigation	  of	  keratinocyte-­‐mediated	  response	  to	  pathogens	  is	  critical	  
for	  advancing	  human	  health,	  particularly	  for	  the	  numerous	  infections	  of	  stratified	  epithelia.	  	  In	  
order	  to	  gain	  a	  clear	  picture	  of	  how	  keratinocytes	  function	  in	  the	  systemic	  immune	  response,	  a	  




	   RNA	  interference	  (RNAi)	  is	  a	  post-­‐transcriptional	  regulatory	  mechanism	  that	  is	  broadly	  
conserved	  across	  most	  eukaryotes.	  	  The	  RNAi	  pathway	  has	  grown	  to	  encompass	  a	  family	  of	  
small,	  non-­‐coding	  RNA	  molecules	  that	  function	  to	  specifically	  repress	  gene	  expression	  at	  the	  
RNA	  level.	  	  The	  discovery	  of	  RNA	  interference	  was	  groundbreaking	  in	  that	  it	  uncovered	  an	  
entirely	  novel	  function	  for	  RNA	  molecules	  as	  regulators	  within	  the	  cell.	  	  RNAi	  was	  first	  
discovered	  and	  characterized	  as	  an	  exogenous	  gene	  silencing	  tool	  in	  C.	  Elegans	  (Fire	  et	  al.	  1998).	  	  
Since	  its	  discovery,	  RNAi	  has	  continually	  been	  developed	  as	  a	  synthetic	  gene	  silencing	  
mechanism	  to	  be	  used	  as	  a	  molecular	  biology	  tool	  and	  eventually	  as	  a	  therapeutic.	  
	   In	  1993,	  the	  first	  endogenous	  small	  RNA	  duplexes	  were	  discovered.	  	  In	  C.	  Elegans,	  the	  
lin-­‐4	  gene	  was	  found	  to	  encode	  a	  small	  RNA	  with	  antisense	  complementarity	  to	  developmental	  
regulator	  LIN-­‐14.	  	  Lin-­‐4	  was	  widely	  known	  to	  spatially	  and	  temporally	  control	  developmental	  
regulator	  LIN-­‐14	  in	  a	  repressive	  fashion.	  	  However,	  the	  lin-­‐4	  gene	  was	  found	  not	  to	  encode	  a	  
protein,	  but	  rather	  two	  small	  RNA	  products	  with	  complementarity	  to	  regions	  in	  the	  LIN-­‐14	  3’	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un-­‐translated	  region	  (UTR)	  (Lee	  et	  al.	  1993).	  	  At	  the	  same	  time,	  it	  was	  revealed	  that	  these	  
complementary	  regions	  in	  the	  3’UTR	  were	  necessary	  and	  sufficient	  for	  lin-­‐4	  regulation	  of	  LIN-­‐14	  
(Wightman	  et	  al.	  1993).	  	  These	  discoveries	  were	  revolutionary	  in	  that	  they	  established	  RNAi	  as	  a	  
cellular-­‐encoded	  gene	  regulation	  tool	  and	  suggested	  a	  mechanism	  for	  its	  function.	  	  More	  of	  
these	  molecules	  were	  subsequently	  identified,	  and	  the	  term	  “microRNA”	  was	  coined	  in	  2001	  
(Lee	  et	  al.	  2001;	  Lau	  et	  al.	  2001).	  	  MicroRNAs	  (miRNAs)	  are	  present	  in	  most	  eukaryotic	  
organisms,	  ranging	  from	  yeast	  (Drinnenberg	  et	  al.	  2009)	  to	  mammals	  (Elbashir	  et	  al.	  2001a).	  
	  
miRNA	  BIOGENESIS	  AND	  FUNCTION	  
	   miRNAs	  are	  short,	  21-­‐22	  nucleotide,	  single-­‐stranded	  RNA	  molecules.	  	  They	  serve	  as	  fine	  
tuners	  of	  gene	  expression	  during	  development	  and	  a	  variety	  of	  stress	  conditions.	  	  miRNAs	  
repress	  gene	  expression	  of	  their	  targets,	  acting	  to	  prevent	  translation	  of	  specific	  messenger	  
RNAs	  (mRNAs).	  	  miRNAs	  cause	  destabilization,	  translational	  inhibition,	  or	  in	  unique	  cases,	  
cleavage	  of	  specific	  mRNAs.	  	  During	  the	  process	  of	  targeting,	  miRNAs	  are	  incorporated	  into	  a	  
complex	  termed	  RISC	  (RNA-­‐induced	  silencing	  complex).	  	  The	  miRNA	  guide	  strand	  is	  directly	  
bound	  by	  an	  argonaute	  protein,	  and	  directs	  RISC	  to	  a	  set	  of	  target	  mRNAs.	  	  miRNA	  targeting	  is	  
determined	  by	  sequence	  complementarity.	  	  A	  7-­‐mer	  within	  the	  mature	  miRNA,	  referred	  to	  as	  
the	  seed	  sequence,	  directs	  the	  vast	  majority	  of	  miRNA	  targeting.	  	  This	  seed	  sequence	  base	  pairs	  
with	  complementary	  motifs	  in	  the	  3’	  UTR	  of	  the	  mRNA,	  resulting	  in	  repression	  of	  the	  message	  
mediated	  by	  the	  RISC	  proteins.	  
	   Most	  miRNAs	  are	  encoded	  similarly	  to	  protein-­‐coding	  genes.	  	  Most	  miRNAs	  
characterized	  to	  date	  are	  transcribed	  by	  RNA	  polymerase	  II	  (Pol	  II),	  forming	  a	  primary	  transcript	  
that	  is	  processed	  and	  exported	  from	  the	  nucleus	  (Figure	  2).	  	  miRNAs	  are	  encoded	  both	  in	  
independent	  transcripts	  and	  intronic	  regions,	  although	  many	  miRNAs	  are	  generated	  from	  a	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distinct	  locus	  with	  a	  unique	  promoter	  (Bartel	  2004).	  	  The	  subset	  of	  intronic	  miRNAs	  are	  generally	  
encoded	  on	  the	  same	  strand	  as	  the	  mRNA,	  and	  processed	  from	  introns	  in	  a	  similar	  manner	  as	  
snoRNAs.	  (Bartel	  2004).	  	  A	  large	  subset	  of	  miRNAs,	  particularly	  in	  Drosophila,	  occur	  in	  clusters.	  	  
Multiple	  miRNAs	  are	  co-­‐transcribed	  and	  subsequently	  processed	  from	  poly-­‐cistronic	  primary	  
transcripts.	  	  Clustered	  miRNAs	  often	  share	  related	  sequences,	  although	  this	  is	  not	  a	  requirement	  
or	  determinant	  for	  clustering	  (Lagos-­‐Quintana	  et	  al.	  2001;	  Lau	  et	  al.	  2001).	  	  Transcription	  of	  
	  
Figure	  2.	  miRNAs	  are	  transcribed	  in	  the	  nucleus	  via	  RNA	  pol	  II-­‐dependent	  transcription.	  	  The	  long	  
primary	  transcript	  (pri-­‐miRNA)	  contains	  a	  conserved	  hairpin	  structure	  that	  is	  recognized	  by	  the	  
drosha/DGCR8	  microprocessor	  complex.	  	  Drosha	  cleaves	  the	  base	  of	  the	  stem	  to	  generate	  the	  
precursor	  miRNA	  (pre-­‐miRNA),	  leaving	  a	  2	  nt	  overhang	  on	  the	  3’	  arm.	  	  Pre-­‐miRNAs	  are	  actively	  
transported	  out	  of	  the	  nucleus	  by	  exportin-­‐5,	  which	  recognizes	  the	  hairpin	  structure.	  	  In	  the	  cytosol,	  
the	  pre-­‐miRNA	  undergoes	  a	  final	  processing	  step	  mediated	  by	  the	  RNaseIII-­‐type	  enzyme	  dicer.	  	  Dicer	  
cleaves	  the	  hairpin	  loop,	  also	  leaving	  a	  2	  nt	  overhang	  at	  the	  3’	  end.	  	  The	  guide	  strand	  of	  the	  mature	  
miRNA	  is	  then	  loaded	  onto	  an	  argonaute	  (Ago)	  protein	  and	  incorporated	  into	  RISC.	  	  The	  seed	  
sequence,	  located	  between	  nucleotides	  2-­‐8	  at	  the	  5’	  end	  of	  the	  miRNA,	  directs	  RISC	  to	  mRNA	  targets	  
by	  complementary	  base-­‐pairing.	  	  Targeting	  by	  RISC	  can	  result	  in	  mRNA	  cleavage,	  de-­‐stabilization,	  or	  
translational	  inhibition.	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miRNA	  genes	  by	  Pol	  II	  produces	  a	  long,	  primary	  transcript	  that	  remains	  in	  the	  nucleus	  (Lee	  et	  al.	  
2002).	  	  Within	  these	  primary	  transcripts	  (pri-­‐miRNA),	  there	  is	  a	  conserved	  stem-­‐hairpin-­‐loop	  
structure	  (Lagos-­‐Quintana	  et	  al.	  2001).	  	  The	  hairpin	  is	  cleaved	  by	  the	  nuclear	  RNase	  III	  enzyme	  
drosha,	  resulting	  in	  a	  70	  nt	  precursor	  miRNA	  (pre-­‐miRNA)	  (Figure	  2).	  	  Drosha	  cleaves	  near	  the	  
base	  of	  the	  stem,	  leaving	  at	  2	  nt	  overhang	  on	  the	  3’	  arm	  (Lee	  et	  al.	  2003).	  	  Drosha	  acts	  in	  concert	  
with	  pasha/DGCR8	  as	  part	  of	  the	  microprocessor	  complex.	  	  DGCR8	  is	  essential	  for	  miRNA	  
processing,	  as	  its	  ablation	  results	  in	  accumulation	  of	  primary	  transcript	  and	  loss	  of	  mature	  
miRNA	  (Denli	  et	  al.	  2004).	  	  Transport	  of	  this	  precursor	  out	  of	  the	  nucleus	  requires	  active	  export	  
by	  exportin-­‐5	  (Yi	  et	  al.	  2003)	  (Figure	  2).	  	  Once	  in	  the	  cytosol,	  pre-­‐miRNAs	  undergo	  a	  final	  
cleavage	  step	  to	  yield	  the	  22	  nt	  mature	  form.	  	  Because	  of	  its	  previously	  identified	  involvement	  in	  
cleavage	  of	  long,	  dsRNA	  into	  siRNAs,	  the	  RNase	  III-­‐type	  endonuclease	  dicer	  was	  predicted	  by	  
many	  groups	  to	  be	  responsible	  for	  cleavage	  of	  70	  nt	  pre-­‐miRNA	  into	  the	  22	  nt	  mature	  form.	  	  
Conclusive	  evidence	  was	  provided	  when	  dicer	  was	  knocked	  out	  in	  a	  mouse	  model,	  and	  ablation	  
of	  mature	  miRNAs	  was	  observed	  (Grishok	  et	  al.	  2001;	  Hutvágner	  et	  al.	  2001).	  	  Dicer	  recognizes	  
the	  double-­‐stranded	  pre-­‐miRNA	  at	  the	  stem-­‐loop	  region.	  	  It	  cleaves	  the	  dsRNA	  stem	  proximal	  to	  
the	  loop,	  once	  again	  leaving	  the	  3’	  end	  2	  nt	  overhang	  typical	  of	  RNase	  III-­‐type	  endonucleases	  
(Figure	  2).	  	  The	  resulting	  mature	  miRNA	  duplex	  contains	  two	  2	  nt	  overhangs	  at	  the	  3’	  end	  of	  
each	  strand,	  derived	  from	  cleavage	  events	  by	  both	  dicer	  and	  drosha.	  	  Recently,	  a	  dicer-­‐
independent	  miRNA	  pathogenesis	  pathway	  was	  discovered	  (Cheloufi	  et	  al.	  2010;	  Cifuentes	  et	  al.	  
2010).	  	  miR-­‐451,	  which	  was	  observed	  in	  the	  mature	  form	  in	  the	  absence	  of	  dicer,	  was	  found	  to	  
be	  cleaved	  by	  argonaute	  2	  (ago2).	  	  Ago2	  performs	  catalytic	  function,	  referred	  to	  as	  “slicer”	  
activity,	  in	  order	  to	  cleave	  dsRNA	  during	  siRNA	  (perfect	  match)	  targeting.	  	  In	  mammals,	  ago2	  is	  
the	  only	  argonaute	  family	  member	  that	  maintains	  this	  catalytic	  activity.	  	  Dicer-­‐independent	  pre-­‐
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miRNA	  is	  loaded	  into	  the	  RNA	  binding	  groove	  in	  ago2,	  where	  it	  is	  cleaved	  twice	  to	  produce	  the	  
mature	  form	  (Cheloufi	  et	  al.	  2010).	  
	   Following	  the	  miRNA’s	  maturation,	  miRNA	  silencing	  is	  mechanistically	  similar	  to	  the	  
RNAi	  pathway.	  	  Once	  the	  mature	  miRNA	  is	  released	  into	  the	  cytosol,	  it	  is	  loaded	  onto	  an	  
argonaute	  protein	  and	  becomes	  associated	  with	  RISC	  (Martinez	  et	  al.	  2002)	  (Figure	  2).	  	  
Argonaute	  is	  essential	  for	  RISC	  function,	  and	  is	  present	  in	  RISCs	  purified	  from	  many	  different	  
species	  (Hammond	  et	  al.	  2001).	  	  miRNAs	  exist	  briefly	  in	  a	  duplex	  form,	  immediately	  following	  
processing	  by	  dicer	  but	  prior	  to	  incorporation	  into	  RISC.	  	  The	  strand	  responsible	  for	  targeting,	  
referred	  to	  as	  the	  guide	  strand,	  is	  biochemically	  identical	  to	  the	  complementary	  (star)	  strand.	  	  It	  
is	  hypothesized	  that	  argonautes	  distinguish	  between	  these	  two	  strands	  by	  sensing	  the	  strength	  
of	  base	  pairs	  at	  the	  5’	  end	  of	  each	  strand.	  	  The	  strand	  with	  the	  loosest	  5’	  base	  pairing	  becomes	  
bound	  to	  argonaute,	  and	  the	  other	  strand	  is	  stripped	  away	  and	  degraded	  (Bartel	  2004).	  	  Once	  
the	  miRNA	  guide	  strand	  has	  been	  bound	  by	  an	  argonaute,	  it	  becomes	  fully	  associated	  with	  RISC.	  	  
Human	  RISC	  is	  composed	  of	  an	  argonaute	  protein	  in	  complex	  with	  Gemin3	  and	  Gemin4	  
(Mourelatos	  et	  al.	  2002).	  	  The	  functions	  of	  Gemin3	  and	  4	  in	  RISC	  are	  largely	  unknown.	  	  	  
Argonautes	  are	  the	  best-­‐studied	  component	  of	  the	  mammalian	  RISC	  complex.	  	  In	  mammals,	  
there	  are	  four	  members	  of	  the	  argonaute	  family	  (ago1-­‐4).	  	  They	  all	  contain	  similar	  structures,	  
and	  all	  are	  capable	  of	  incorporating	  into	  the	  miRNA-­‐induced	  RISC.	  	  miRNAs	  appear	  to	  be	  
nonspecifically	  loaded	  onto	  different	  argonaute	  family	  members.	  	  miRNA	  loading	  generally	  
correlates	  with	  argonaute	  abundance.	  	  In	  epidermal	  keratinocytes,	  ago2	  was	  found	  to	  bind	  60%	  
of	  miRNAs,	  followed	  by	  ago1	  and	  ago3.	  	  In	  the	  absence	  of	  one	  argonaute	  family	  member,	  other	  
members	  are	  able	  to	  compensate	  and	  bind	  additional	  miRNAs	  (Wang	  et	  al.	  2012).	  	  The	  
argonautes	  consist	  of	  two	  major	  conserved	  domains.	  	  The	  PAZ	  domain,	  near	  the	  N-­‐terminus,	  
resembles	  a	  single	  and	  double-­‐stranded	  RNA	  binding	  domain,	  and	  is	  thought	  to	  be	  responsible	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for	  binding	  the	  miRNA	  guide	  strand,	  and	  possibly	  the	  miRNA-­‐mRNA	  duplex.	  	  The	  downstream	  
PIWI	  domain	  contains	  an	  RNaseH-­‐like	  endonuclease	  site,	  which	  is	  catalytically	  active	  only	  in	  
ago2.	  	  This	  site	  is	  responsible	  for	  mRNA	  cleavage	  in	  perfect-­‐match	  targeting	  scenarios	  (Filipowicz	  
et	  al.	  2008).	  	  After	  becoming	  bound	  by	  argonaute,	  the	  single-­‐stranded	  miRNA	  guides	  RISC	  to	  
mRNA	  targets	  based	  on	  sequence	  complementarity.	  
	   Both	  miRNAs	  and	  siRNAs	  recognize	  target	  mRNAs	  via	  complementary	  base	  pairing	  
(Figure	  2).	  	  However,	  miRNAs	  and	  siRNAs	  recognize	  targets	  in	  slightly	  different	  manners,	  and	  
result	  in	  different	  mechanisms	  of	  translational	  repression.	  	  siRNAs	  pair	  completely	  with	  their	  
target	  mRNAs,	  interacting	  along	  the	  full	  length	  of	  the	  siRNA.	  	  A	  perfect	  match	  between	  the	  
siRNA	  and	  the	  mRNA	  triggers	  a	  conformational	  change	  in	  argonaute,	  bringing	  the	  catalytic	  
domain	  of	  ago2	  in	  close	  proximity	  with	  the	  mRNA	  and	  facilitating	  cleavage.	  	  Unlike	  siRNAs,	  
miRNAs	  pair	  with	  targets	  through	  a	  7-­‐mer	  motif	  referred	  to	  as	  a	  seed	  sequence.	  	  The	  seed	  
sequence	  is	  located	  in	  the	  5’	  end	  of	  the	  miRNA,	  spanning	  nucleotides	  2-­‐8	  (Lai	  2002).	  	  This	  5’	  
region	  preferentially	  determines	  targeting	  by	  miRNAs,	  and	  to	  some	  extent	  in	  siRNAs.	  	  This	  
conclusion	  was	  reached	  following	  evidence	  of	  enriched	  sequence	  conservation	  in	  the	  seed	  
region	  of	  related	  miRNAs	  or	  orthologs	  (Bartel	  2004).	  	  Additionally,	  bioinformatic	  predictions	  of	  
miRNA	  targets	  were	  found	  to	  significantly	  increase	  accuracy	  by	  scanning	  for	  sites	  
complementary	  to	  the	  seed	  region,	  compared	  to	  other	  7-­‐mers	  within	  the	  miRNA	  (Jackson	  et	  al.	  
2013;	  Lewis	  et	  al.	  2003).	  	  A	  possible	  contributing	  factor	  to	  preferential	  5’	  end	  targeting	  may	  be	  
the	  structure	  of	  the	  miRNA	  when	  it	  is	  bound	  by	  argonaute.	  	  Argonaute	  appears	  to	  display	  the	  
miRNA’s	  5’	  end	  in	  an	  exposed,	  A-­‐form	  helix	  structure,	  which	  is	  optimized	  for	  base	  pairing	  
interactions	  with	  the	  mRNA	  target	  (Bartel	  2004).	  	  miRNAs	  target	  mRNAs	  predominantly	  in	  the	  3’	  
UTR	  of	  the	  transcript	  (Lai	  2002).	  	  Often,	  a	  single	  mRNA	  will	  have	  multiple	  target	  sites	  in	  its	  3’	  
UTR,	  and	  can	  be	  regulated	  by	  many	  different	  miRNAs.	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   Once	  a	  miRNA	  recognizes	  a	  target,	  it	  can	  prevent	  protein	  synthesis	  by	  several	  different	  
mechanisms.	  	  It	  was	  originally	  thought	  that	  the	  origin	  of	  the	  small	  RNA	  in	  RISC	  determined	  its	  
ability	  to	  cleave	  an	  mRNA	  target.	  	  However,	  in	  rare	  cases	  where	  the	  miRNA	  has	  significant	  
complementarity	  to	  the	  mRNA	  extending	  beyond	  the	  seed	  sequence,	  it	  can	  also	  trigger	  cleavage	  
of	  the	  mRNA	  (Hutvager	  and	  Zamore	  2002).	  	  The	  site	  of	  cleavage	  is	  extremely	  precise,	  and	  
appears	  to	  be	  directed	  between	  bases	  10-­‐11	  of	  the	  miRNA	  (Elbashir	  et	  al.	  2001b).	  	  mRNA	  
cleavage	  is	  mediated	  by	  RISC-­‐incorporated	  ago2,	  which	  possesses	  endonuclease	  activity	  in	  its	  
PIWI	  domain	  (Filipowicz	  et	  al.	  2008).	  	  Ago2	  is	  the	  only	  argonaute	  family	  member	  involved	  in	  the	  
cleavage-­‐based	  RNAi	  pathway,	  as	  it	  is	  the	  only	  homolog	  that	  retains	  catalytic	  activity	  in	  its	  
endonuclease	  domain.	  
	   The	  most	  common	  mechanism	  of	  miRNA	  targeting	  is	  mRNA	  deadenylation	  and	  
destabilization.	  	  Global	  inhibition	  of	  the	  miRNA	  pathway	  results	  in	  broad	  and	  significant	  changes	  
in	  levels	  of	  mRNA	  transcripts	  detected	  by	  micro	  array,	  suggesting	  that	  miRNAs	  act	  significantly	  
at	  the	  level	  of	  mRNA	  stability.	  	  The	  proposed	  mechanism	  of	  action	  begins	  with	  deadenylation	  at	  
the	  poly-­‐A	  tail.	  	  Argonaute	  recruits	  GW182	  to	  RISC	  through	  its	  PIWI	  domain.	  	  GW182	  then	  
synergizes	  with	  the	  CCR4-­‐NOT	  deadenylating	  complex	  to	  shorten	  the	  poly-­‐A	  tail	  (Behm-­‐Ansmant	  
et	  al.	  2006).	  	  This	  initiates	  a	  cascade	  of	  mRNA	  degradation,	  starting	  with	  exosome-­‐mediated	  3’-­‐
5’	  degradation.	  	  Decapping	  soon	  follows	  at	  the	  5’	  end,	  catalyzed	  by	  DCP1	  and	  DCP2.	  	  Once	  
decapping	  has	  occurred,	  the	  exonuclease	  XRN1	  begins	  5’-­‐3’	  degradation.	  	  miRNA-­‐mediated	  
repression	  is	  relieved	  in	  the	  absence	  of	  DCP1	  and	  DCP2,	  indicating	  a	  requirement	  for	  
deadenylation	  and	  decapping	  in	  miRNA-­‐mediated	  mRNA	  decay	  (Behm-­‐Ansmant	  et	  al.	  2006).	  	  
High	  throughput	  screening	  methods,	  such	  as	  micro	  array	  and	  quantitative	  PCR,	  enable	  rapid	  
detection	  of	  miRNA	  targets	  that	  are	  repressed	  via	  mRNA	  decay.	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miRNA	  regulation	  also	  occurs	  through	  translational	  repression	  in	  the	  absence	  of	  mRNA	  
degradation	  or	  cleavage.	  	  This	  canonical	  distinction	  from	  the	  RNAi	  pathway	  was	  first	  elucidated	  
in	  the	  study	  of	  C.	  Elegans	  miRNA	  lin-­‐4.	  	  Lin-­‐4	  was	  known	  to	  downregulate	  expression	  of	  the	  LIN-­‐
14	  protein	  product,	  but	  had	  no	  effect	  on	  mRNA	  levels	  (Whightman	  et	  al.	  1993).	  	  The	  precise	  
mechanism	  of	  translational	  repression	  has	  not	  yet	  been	  confirmed,	  although	  it	  appears	  to	  be	  
mediated	  by	  argonaute.	  	  miRNA-­‐independent	  attachment	  of	  ago2	  to	  the	  3’	  UTR	  of	  reporter	  
transcripts	  mimicked	  miRNA-­‐mediated	  repression	  at	  the	  protein	  level,	  but	  had	  no	  effect	  on	  
mRNA	  stability	  (Pillai	  et	  al.	  2004).	  	  Mechanisms	  of	  ago2-­‐mediated	  repression	  were	  further	  
investigated,	  leading	  to	  the	  current	  hypothesis	  that	  RISC	  prevents	  translation	  initiation.	  	  mRNA	  
circularization	  is	  essential	  for	  translation	  initiation	  by	  promoting	  binding	  of	  initiation	  factor	  eIF4E	  
to	  the	  m7G	  cap	  on	  the	  mRNA.	  	  Circularization	  occurs	  via	  interaction	  of	  cap-­‐binding	  protein	  eIF4G	  
with	  PABP1	  (polyadenylate-­‐binding	  protein	  1).	  	  RISC	  appears	  to	  inhibit	  translation	  initiation	  
through	  some	  form	  of	  interaction	  with	  the	  mRNA	  cap	  structure.	  	  This	  is	  supported	  by	  data	  
demonstrating	  that	  miRNAs	  were	  unable	  to	  repress	  expression	  of	  reporters	  translated	  from	  an	  
internal	  ribosome	  entry	  site	  (IRES)	  or	  bi-­‐cistronic	  mRNA	  (Pillai	  et	  al.	  2005).	  	  Ago2	  was	  also	  
implicated	  as	  the	  catalyst	  for	  m7G	  cap-­‐dependent	  repression,	  as	  artificial	  tethering	  of	  Ago2	  to	  
the	  3’	  UTR	  of	  reporter	  transcripts	  exhibited	  identical	  repression	  patterns	  (Pillai	  et	  al.	  2005).	  	  It	  is	  
likely	  that	  ago2	  prevents	  cap-­‐dependent	  translation	  by	  preventing	  eIF4E	  from	  interacting	  with	  
the	  m7G	  cap.	  	  Ago2	  contains	  a	  region	  in	  between	  the	  PAZ	  and	  PIWI	  domains	  that	  is	  similar	  to	  the	  
cap-­‐binding	  region	  of	  eIF4E,	  and	  binds	  m7G	  caps	  via	  a	  group	  of	  aromatic	  residues.	  	  Mutation	  of	  
these	  residues	  abolishes	  translational	  repression	  by	  ago2,	  suggesting	  that	  it	  acts	  as	  a	  
competitive	  inhibitor	  for	  eIF4E	  (Kiriakidou	  et	  al.	  2007).	  	  Interaction	  with	  eIF4E	  proposes	  a	  
potential	  driving	  force	  behind	  3’	  UTR	  restricted	  miRNA	  targeting,	  as	  it	  brings	  argonautes	  into	  
close	  proximity	  with	  eIF4E,	  eIF4G,	  and	  PABP1	  during	  mRNA	  circularization.	  	  miRNAs	  may	  also	  act	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to	  repress	  translation	  during	  the	  elongation	  phase.	  	  This	  is	  mainly	  supported	  by	  evidence	  that	  
target	  mRNAs,	  as	  well	  as	  ago-­‐miRNA	  complexes,	  co-­‐precipitate	  with	  polysomes	  (Filipowicz	  et	  al.	  
2008).	  
	  
RNAi	  AS	  AN	  ANTIVIRAL	  DEFENSE	  MECHANISM	  
	   The	  RNAi	  pathway	  has	  been	  theorized	  to	  be	  an	  archaic	  anti-­‐viral	  defense	  mechanism.	  	  
Because	  of	  its	  ability	  to	  cleave	  or	  repress	  RNA,	  it	  is	  poised	  to	  act	  against	  foreign	  nucleic	  acids.	  	  
RNAi	  has	  already	  been	  established	  as	  an	  innate	  antiviral	  defense	  in	  plants	  (Baulcombe	  2004;	  
Voinnet	  2005).	  	  The	  RNAi	  pathway	  can	  function	  in	  several	  ways	  to	  restrict	  viral	  replication.	  	  
Firstly,	  dicer’s	  ability	  to	  non-­‐specifically	  cleave	  long	  dsRNAs	  into	  fragments	  has	  the	  potential	  to	  
destroy	  viral	  nucleic	  acid	  replication	  intermediates	  in	  RNA	  viruses.	  	  This	  theory	  is	  supported	  by	  
studies	  in	  Drosophila	  demonstrating	  increased	  susceptibility	  to	  viral	  infection	  in	  the	  absence	  or	  
inhibition	  of	  dicer	  (van	  Rij	  et	  al.	  2006;	  Wang	  et	  al.	  2006).	  	  In	  Drosophila,	  dicer	  function	  is	  split	  
between	  two	  proteins.	  	  Dicer-­‐1	  is	  responsible	  for	  maturation	  of	  miRNAs,	  while	  dicer-­‐2	  produces	  
siRNAs	  by	  cleavage	  of	  long	  dsRNA.	  	  Genetic	  ablation	  of	  dicer-­‐2	  increased	  susceptibility	  to	  Flock	  
House	  Virus	  (FHV)	  and	  Cricket	  Paralysis	  Virus	  (CrPV),	  both	  single	  stranded	  RNA	  (ssRNA)	  viruses	  
(Wang	  et	  al.	  2006).	  	  In	  the	  absence	  of	  dicer-­‐2	  or	  Ago-­‐2,	  viral	  RNA	  was	  greatly	  increased,	  and	  
insect	  mortality	  was	  dramatically	  accelerated	  (Wang	  et	  al.	  2006).	  	  Interestingly,	  22	  nt	  siRNAs	  
accumulated	  during	  CrPV	  infection	  in	  vitro,	  potentially	  suggesting	  a	  mechanism	  for	  dicer	  as	  a	  
producer	  of	  anti-­‐viral	  siRNAs	  (Wang	  et	  al.	  2006).	  	  Perhaps	  the	  strongest	  evidence	  for	  the	  
importance	  of	  RNAi	  in	  the	  antiviral	  response	  is	  that	  both	  FHV	  and	  CrPV	  encode	  an	  RNA	  silencing	  
suppressor	  (RSS).	  	  Viruses	  are	  under	  great	  selection	  pressure,	  and	  dispensable	  nucleic	  acids	  are	  
rapidly	  lost	  from	  the	  genome.	  	  The	  presence	  of	  a	  conserved	  gene	  product	  in	  many	  viruses	  
designed	  to	  counteract	  RNA	  silencing	  indicates	  the	  importance	  of	  this	  pathway	  in	  the	  host	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response.	  	  FHV	  and	  CrPV	  are	  both	  extremely	  small	  viruses,	  containing	  only	  two	  open	  reading	  
frames	  (ORFs).	  	  In	  each	  virus,	  one	  open	  reading	  frame	  is	  responsible	  for	  counteracting	  the	  
effects	  of	  host-­‐mediated	  RNA	  silencing.	  	  The	  RSS	  function	  was	  identified	  by	  determining	  which	  
genomic	  region	  was	  specifically	  dispensable	  for	  infection	  in	  dicer-­‐2	  or	  Ago-­‐2	  null	  flies	  but	  
required	  for	  infection	  in	  WT	  animals	  (Wang	  et	  al.	  2006).	  	  The	  B2	  protein	  of	  FHV	  was	  identified	  to	  
possess	  RSS	  activity,	  and	  was	  used	  in	  future	  studies	  to	  specifically	  inhibit	  dicer-­‐mediated	  
cleavage	  of	  long	  dsRNA	  (van	  Rij	  et	  al.	  2006,	  Wang	  et	  al.	  2006).	  
	   A	  second	  potential	  mechanism	  for	  viral	  restriction	  by	  the	  RNAi	  pathway	  is	  the	  
incorporation	  of	  virus-­‐specific	  siRNAs	  processed	  by	  dicer	  into	  RISC.	  	  This	  is	  supported	  by	  the	  
finding	  that	  Ago-­‐2,	  the	  core	  catalytic	  component	  of	  RISC,	  is	  required	  for	  antiviral	  defense	  in	  
Drosophila.	  	  Ago-­‐2	  null	  flies	  were	  challenged	  with	  both	  CrPV	  and	  Drosophila	  C	  Virus	  (DCV).	  	  In	  
both	  cases,	  Ago-­‐2	  null	  animals	  exhibited	  increased	  and	  accelerated	  mortality,	  as	  well	  as	  
significantly	  higher	  loads	  of	  viral	  RNA.	  	  Loss	  of	  Ago-­‐2	  produced	  a	  more	  severe	  phenotype	  during	  
infection	  than	  loss	  of	  dicer-­‐2,	  suggesting	  a	  critical	  role	  for	  RISC	  in	  viral	  restriction	  (van	  Rij	  et	  al.	  
2006).	  	  An	  RSS	  was	  also	  identified	  in	  DCV.	  	  Using	  a	  luciferase	  reporter	  system,	  DCV	  infection	  was	  
found	  to	  block	  silencing	  of	  the	  reporter	  by	  a	  long	  (~500	  nt)	  dsRNA.	  	  Silencing	  mediated	  by	  
transfection	  of	  21	  nt	  siRNAs	  was	  unaffected,	  suggesting	  that	  the	  DCV	  RSS	  acts	  at	  the	  level	  of	  
dicer	  processing.	  	  Its	  target	  was	  further	  narrowed	  to	  dicer-­‐2,	  by	  the	  finding	  that	  ratios	  of	  mature	  
to	  precursor	  miRNAs	  were	  unchanged	  during	  infection	  (van	  Rij	  et	  al.	  2006).	  	  While	  RNA	  silencing	  
restriction	  acts	  across	  different	  virus	  families,	  the	  insect	  viruses	  tested	  all	  share	  a	  commonality	  
in	  that	  they	  are	  single	  stranded	  RNA	  viruses.	  	  RNAi-­‐based	  mechanisms	  of	  RNA	  virus	  restriction	  
are	  relatively	  easy	  to	  conjure,	  as	  both	  dicer	  and	  ago2	  are	  designed	  to	  cleave	  dsRNA,	  a	  universal	  
replication	  intermediate	  for	  RNA	  viruses.	  The	  RNAi	  pathway	  has	  been	  firmly	  established	  as	  an	  
innate	  antiviral	  mechanism	  in	  both	  plants	  and	  Drosophila,	  but	  has	  yet	  to	  be	  studied	  in	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mammalian	  systems	  or	  outside	  of	  RNA	  virus	  challenge.	  	  Additionally,	  RNAi-­‐mediated	  antiviral	  
studies	  to	  date	  have	  been	  restricted	  to	  siRNAs,	  with	  the	  potential	  involvement	  of	  the	  
endogenous	  miRNA	  remaining	  elusive.	  	  While	  dicer-­‐mediated	  cleavage	  of	  replication	  
intermediates	  is	  an	  unlikely	  restriction	  mechanism	  for	  non-­‐RNA	  viruses,	  it	  is	  certainly	  possible	  
that	  virus-­‐specific	  siRNAs	  or	  miRNAs	  act	  through	  RISC	  to	  repress	  viral	  mRNAs.	  
	   Recently,	  it	  was	  reported	  that	  HSV-­‐1	  suppressed	  exogenous	  siRNA	  silencing	  in	  human	  
cells.	  	  A	  hairpin	  was	  designed	  to	  result	  in	  production	  of	  a	  miRNA	  (through	  the	  canonical	  
biogenesis	  pathway)	  with	  perfect	  complementarity	  to	  eGFP.	  	  The	  synthetic	  miRNA	  effectively	  
caused	  degradation	  of	  eGFP	  mRNA	  upon	  co-­‐transfection.	  	  However,	  HSV-­‐1	  infection	  reversed	  
this	  degradation,	  resulting	  in	  eGFP	  mRNA	  stabilization	  (Wu	  et	  al.	  2009).	  	  These	  data	  suggest	  that	  
HSV-­‐1	  encodes	  a	  gene	  product	  with	  RSS	  function.	  	  To	  determine	  the	  relevance	  for	  RNA	  silencing	  
suppression	  for	  HSV-­‐1	  replication,	  human	  embryonic	  kidney	  293	  cells	  transformed	  with	  SV-­‐40	  
large	  T	  antigen	  (HEK293T)	  knocked	  down	  for	  ago2	  via	  siRNA	  were	  infected	  with	  HSV-­‐1,	  and	  viral	  
titers	  were	  compared	  to	  virus	  produced	  from	  wild-­‐type	  (WT)	  cells.	  	  Viral	  titers	  were	  significantly	  
enhanced	  in	  the	  absence	  of	  ago2,	  suggesting	  an	  antiviral	  restriction	  mechanism	  mediated	  by	  
RISC	  (Wu	  et	  al.	  2009).	  	  The	  evidence	  of	  action	  by	  human	  RISC	  against	  a	  dsDNA	  virus	  provides	  
novel	  insight	  into	  the	  potential	  antiviral	  functions	  of	  RNAi	  in	  mammals,	  and	  necessitates	  further	  
investigation	  in	  this	  area.	  
	  
HERPES	  SIMPLEX	  VIRUS	  
	   Herpes	  Simplex	  Virus	  Type	  1	  (HSV-­‐1)	  is	  a	  large,	  double-­‐stranded	  DNA	  virus	  belonging	  to	  
the	  herpesviridae	  family.	  	  Along	  with	  HSV-­‐2,	  pseudorabies	  virus,	  varicella-­‐zoster	  virus,	  and	  
equine	  herpesvirus	  1,	  it	  forms	  the	  subfamily	  of	  alphaherpesvirinae.	  	  Alphaherpesvirinae	  carry	  
out	  lytic	  infections	  in	  stratified	  epithelia	  including	  mucosal	  and	  cornified	  tissues.	  	  The	  hosts	  of	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viral	  replication	  are	  keratinocytes	  residing	  in	  the	  skin	  or	  genital	  tract.	  HSV-­‐1	  predominantly	  
replicates	  in	  the	  skin,	  at	  the	  site	  of	  cutaneous-­‐mucosal	  epithelial	  junctions	  such	  as	  areas	  around	  
the	  mouth.	  	  Recently,	  however,	  HSV-­‐1	  has	  been	  detected	  with	  increasing	  frequency	  in	  the	  
genital	  tract	  of	  individuals	  diagnosed	  with	  genital	  herpes	  (Xu	  et	  al.	  2006).	  	  HSV-­‐2,	  the	  canonical	  
causative	  agent	  of	  genital	  herpes,	  results	  in	  ano-­‐genital	  lesions.	  	  HSV-­‐1	  infections	  are	  commonly	  
acquired	  during	  childhood	  due	  to	  direct	  skin	  contact,	  while	  the	  vast	  majority	  of	  HSV-­‐2	  infections	  
are	  sexually	  transmitted.	  	  Aside	  from	  their	  distinct	  tissue	  tropisms,	  HSV-­‐1	  and	  HSV-­‐2	  carry	  out	  
very	  similar	  life	  cycles.	  	  Initial	  exposure	  to	  Herpes	  Simplex	  viruses	  results	  in	  a	  productive	  lytic	  
replication	  phase,	  with	  sites	  of	  active	  virus	  replication	  producing	  visible	  sores.	  	  The	  virus	  then	  
enters	  sensory	  ganglia,	  and	  spreads	  through	  the	  neural	  network	  by	  traveling	  along	  the	  axons	  of	  
individual	  neurons.	  	  In	  the	  neuron,	  the	  virus	  adopts	  a	  latent	  life	  cycle-­‐	  it	  becomes	  a	  quiescent	  
episome,	  producing	  low	  levels	  of	  a	  non-­‐coding	  transcript.	  	  This	  allows	  the	  virus	  to	  evade	  immune	  
detection	  and	  persist	  indefinitely	  in	  the	  host.	  	  Reactivation	  of	  the	  virus	  to	  produce	  a	  lytic	  
“outbreak”	  intermittently	  occurs,	  likely	  driven	  by	  stress.	  	  During	  reactivation,	  the	  virus	  reverses	  
its	  travel	  route	  along	  neuronal	  axons	  back	  to	  its	  tissue	  of	  origin,	  where	  it	  once	  again	  enters	  a	  
lytic	  replication	  phase	  in	  keratinocytes.	  
Herpes	  Simplex	  viruses	  are	  the	  most	  prevalent	  members	  of	  the	  herpesviridae	  family.	  	  
Data	  from	  the	  1999-­‐2004	  U.S.	  National	  Health	  and	  Nutrition	  Surveys	  (NHANES)	  found	  57.7%	  of	  
the	  U.S.	  population	  to	  be	  infected	  with	  HSV-­‐1,	  and	  16.2%	  infected	  with	  HSV-­‐2,	  based	  on	  
seroprevalence	  analysis	  (Xu	  et	  al.	  2006).	  	  The	  CDC	  reported	  similar	  findings	  in	  their	  analysis	  of	  
updated	  2005-­‐2008	  NHANES	  data,	  determining	  the	  fraction	  of	  HSV-­‐2	  positive	  individuals	  
between	  14	  and	  49	  years	  of	  age	  to	  be	  17%	  (CDC,	  2006).	  	  While	  most	  Herpes	  Simplex	  virus	  
infections	  are	  benign	  and	  often	  asymptomatic,	  they	  can	  pose	  significant	  risks	  to	  human	  health.	  	  
Because	  of	  their	  neural	  tropism,	  infections	  may	  lead	  to	  encephalitis	  or	  meningitis.	  	  Additionally,	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the	  presence	  of	  genital	  sores	  caused	  by	  HSV-­‐1	  or	  HSV-­‐2	  greatly	  increases	  the	  risk	  of	  HIV	  
transmission.	  	  This	  is	  due	  in	  part	  to	  the	  potential	  for	  direct,	  blood-­‐to-­‐blood	  contact,	  and	  also	  the	  
recruitment	  of	  lymphocytes	  to	  the	  site	  of	  HSV	  replication,	  which	  serve	  as	  hosts	  for	  HIV	  (Ogawa	  
et	  al.	  2013).	  	  Since	  cutaneous	  and	  mucosal	  stratified	  epithelia	  are	  the	  major	  reservoir	  for	  active	  
HSV	  replication	  in	  humans,	  and	  serve	  as	  the	  site	  of	  primary	  infection,	  it	  is	  imperative	  to	  
understand	  how	  keratinocytes	  respond	  to	  infection	  in	  order	  to	  limit	  disease.	  
	   HSV-­‐1	  infection	  begins	  in	  the	  epidermis,	  following	  contact	  with	  an	  infected	  individual.	  	  
The	  virus	  actively	  replicates	  in	  keratinocytes,	  performing	  a	  lytic	  life	  cycle.	  	  The	  virus	  exhibits	  a	  
preference	  for	  proliferative	  basal	  keratinocytes,	  although	  this	  is	  not	  correlated	  with	  receptor	  
expression	  (Schelhaas	  et	  al.	  2003).	  	  Virus	  entry	  can	  proceed	  by	  either	  endocytosis,	  or	  fusion	  at	  
the	  plasma	  membrane,	  depending	  on	  cell	  type.	  	  In	  both	  cases,	  interaction	  with	  viral	  glycoprotein	  
gD	  with	  one	  of	  its	  receptors,	  HVEM,	  nectin-­‐1,	  or	  nectin-­‐2,	  is	  required	  for	  initiation.	  	  The	  
prominent	  method	  of	  HSV-­‐1	  entry	  in	  keratinocytes	  is	  endocytosis	  (Nicola	  et	  al.	  2005).	  	  When	  the	  
virus	  is	  endocytosed,	  it	  follows	  a	  terminal,	  lysosome-­‐destined	  pathway.	  	  The	  virus	  uses	  low	  
endosomal	  pH	  to	  facilitate	  capsid	  opening	  and	  effective	  entry.	  	  Lysomotropic	  agents	  that	  raise	  
endosomal	  pH	  were	  found	  to	  prevent	  HSV-­‐1	  entry	  in	  both	  primary	  and	  immortalized	  human	  
keratinocytes	  (Nicola	  et	  al.	  2005).	  	  Subsequently,	  evidence	  of	  viral	  fusion	  at	  the	  plasma	  
membrane	  was	  revealed	  in	  keratinocytes.	  	  Both	  plasma	  membrane	  fusion	  and	  endocytosis	  
require	  the	  presence	  of	  dynamin,	  which	  is	  involved	  in	  vesicle	  cleavage	  (Rahn	  et	  al.	  2011).	  	  
Additionally,	  cholesterol	  inhibitor	  MβCD	  also	  disrupted	  viral	  entry,	  suggesting	  a	  requirement	  for	  
lipid	  raft-­‐dependent	  endocytosis	  (Rahn	  et	  al.	  2011).	  	  Inside	  the	  endosome,	  a	  second	  gD-­‐receptor	  
interaction	  is	  required	  for	  final	  escape	  into	  the	  cytosol	  (Nicola	  et	  al.	  2004).	  	  Once	  the	  virus	  enters	  
the	  cytosol,	  the	  envelope	  falls	  apart	  and	  releases	  naked	  capsid.	  	  The	  capsid	  then	  travels	  to	  the	  
nuclear	  periphery,	  and	  releases	  its	  DNA	  through	  a	  pore.	  	  Viral	  proteins	  gD,	  gB,	  and	  the	  gH-­‐gL	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dimer	  are	  required	  for	  effective	  trafficking	  to	  the	  nucleus	  (Nicola	  et	  al.	  2004).	  	  The	  viral	  genome	  
remains	  as	  an	  episome	  in	  the	  nucleus,	  where	  transcription	  begins	  in	  a	  highly	  organized	  
temporally	  controlled	  manner.	  	  Viral	  gene	  products	  are	  produced	  in	  three	  distinct	  phases.	  	  First,	  
the	  α	  genes	  are	  produced,	  followed	  by	  the	  β,	  and	  then	  γ	  products.	  	  Synthesis	  of	  β	  and	  γ	  genes	  is	  
dependent	  on	  the	  presence	  of	  the	  preceding	  group.	  	  The	  α	  set	  of	  gene	  products	  consists	  of	  
primarily	  non-­‐structural	  genes,	  and	  is	  synthesized	  between	  3	  and	  4	  hours	  post	  infection.	  	  β	  
genes	  are	  also	  primarily	  non-­‐structural,	  although	  their	  production	  requires	  both	  the	  presence	  of	  
α	  genes	  as	  well	  as	  ongoing	  RNA	  synthesis.	  	  The	  majority	  of	  structural	  genes	  are	  located	  within	  
the	  γ	  group.	  	  γ	  gene	  synthesis	  continues	  up	  to	  12	  hours	  after	  initial	  infection,	  nearing	  the	  time	  
point	  of	  the	  first	  progeny	  virion	  release	  (Honess	  and	  Roizman,	  1974).	  
	  
VIRAL	  miRNA	  
	   Recently,	  the	  search	  for	  novel	  miRNAs	  expanded	  to	  include	  viral	  genomes.	  	  The	  first	  viral	  
miRNAs	  were	  predicted	  and	  validated	  in	  dsDNA	  virus	  families,	  including	  simian	  polyomaviruses	  
(SV-­‐40)	  and	  herpesviruses.	  	  Most	  of	  the	  viral	  miRNAs	  validated	  to	  date	  are	  encoded	  by	  gamma	  
herpesviruses,	  such	  as	  Epstein	  Barr	  Virus	  (EBV)	  and	  Kaposi’s	  sarcoma-­‐Associated	  herpesvirus	  
(KSHV)	  (Pfeffer	  et	  al.	  2004;	  Cai	  et	  al.	  2005).	  	  The	  β	  herpesvirus,	  human	  Cytomegalovirus	  (HCMV)	  
has	  also	  been	  demonstrated	  to	  encode	  functionally	  expressed	  miRNAs	  (Pfeffer	  et	  al.	  2005).	  	  
HSV-­‐1	  also	  encodes	  several	  miRNAs,	  both	  during	  lytic	  and	  latent	  infection.	  	  These	  miRNAs	  were	  
initially	  predicted	  in	  2006	  using	  a	  novel	  virus-­‐specific	  miRNA	  prediction	  algorithm	  (Cui	  et	  al.	  
2006).	  	  Since	  currently	  identified	  viral	  miRNAs	  are	  typically	  not	  conserved	  in	  related	  viral	  species,	  
bioinformatic	  prediction	  algorithms	  for	  viral	  miRNAs	  have	  had	  to	  rely	  predominantly	  on	  
secondary	  structure	  to	  filter	  through	  genomes	  and	  identify	  potential	  miRNAs.	  	  The	  HSV-­‐1	  strain	  
17	  genome	  was	  scanned	  for	  21	  nucleotide	  stretches	  that	  are	  contained	  within	  regions	  predicted	  
INTRODUCTION	   	   	   	  20	  
to	  form	  stem-­‐loop	  structures	  according	  to	  RNA	  folding	  algorithms.	  	  Hits	  were	  then	  filtered	  
according	  to	  GC	  content	  (between	  30-­‐75%),	  and	  their	  location	  relative	  to	  viral	  coding	  regions.	  	  
This	  computational	  approach	  predicted	  24	  mature	  miRNAs	  from	  13	  potential	  precursors,	  
encoded	  at	  11	  different	  loci	  (Cui	  et	  al.	  2006).	  	  One	  of	  these	  miRNAs,	  denoted	  miR-­‐H1,	  was	  
functionally	  validated	  for	  expression	  during	  lytic	  infection	  in	  Vero	  cells.	  	  Antisense	  probes	  
against	  the	  5’	  arm	  of	  the	  pre-­‐miRNA	  sequence	  were	  able	  to	  detect	  both	  60	  nt	  precursor	  and	  a	  
21	  nt	  mature	  transcript	  by	  northern	  blot	  hybridization	  (Cui	  et	  al.	  2006).	  	  The	  mature	  sequence	  of	  
miR-­‐H1	  is	  conserved	  to	  later-­‐isolated	  HSV-­‐1	  and	  HSV-­‐2	  mature	  miR-­‐H6,	  suggesting	  a	  potential	  
common	  function	  during	  viral	  infection	  (Umbach	  et	  al.	  2008;	  Jurak	  et	  al.	  2012).	  
	   HSV-­‐1	  also	  expresses	  a	  long,	  non-­‐coding	  RNA	  transcript	  termed	  latency-­‐associated	  
transcript	  (LAT).	  	  LAT	  is	  the	  only	  viral	  transcript	  produced	  during	  latency,	  and	  is	  thought	  to	  help	  
maintain	  the	  virus	  in	  a	  quiescent	  state.	  	  LAT	  contains	  a	  stable	  2	  kb	  intron,	  and	  an	  unstable	  6.3	  kb	  
exon,	  although	  it	  is	  not	  predicted	  to	  encode	  a	  protein	  (Ferrel	  et	  al.	  1991;	  Kang	  et	  al.	  2006).	  	  LAT	  
was	  found	  to	  encode	  four	  functionally	  expressed	  miRNAs.	  	  miR-­‐H2,	  miR-­‐H3,	  miR-­‐H4,	  and	  miR-­‐H5	  
are	  expressed	  from	  four	  distinct	  miRNA	  precursors	  within	  LAT	  (Umbach	  et	  al.	  2008).	  	  Expression	  
of	  these	  miRNAs	  was	  validated	  in	  vitro	  by	  small	  RNA	  sequencing	  from	  complementary	  DNA	  
(cDNA)	  libraries	  derived	  from	  293T	  cells	  transfected	  with	  a	  LAT-­‐encoding	  plasmid.	  	  These	  results	  
were	  validated	  in	  vivo	  in	  latently	  infected	  mice,	  where	  miR-­‐H2,	  miR-­‐H3,	  and	  miR-­‐H5	  were	  
detected	  by	  deep	  sequencing	  (Umbach	  et	  al.	  2008).	  	  A	  sixth	  viral	  miRNA,	  miR-­‐H6,	  was	  identified	  
in	  the	  cDNA	  libraries	  of	  latently	  infected	  mouse	  ganglia.	  	  miR-­‐H6	  is	  transcribed	  from	  the	  
antisense	  strand	  in	  the	  LAT	  promoter.	  	  The	  stem-­‐loop	  precursor	  for	  miR-­‐H6	  is	  also	  encoded	  at	  
the	  same	  loci	  and	  in	  the	  antisense	  direction	  of	  miR-­‐H1.	  	  Using	  q-­‐RT-­‐PCR	  analysis,	  all	  five	  HSV-­‐1	  
encoded	  miRNAs	  were	  also	  detected	  during	  lytic	  infection	  in	  Vero	  cells	  (Umbach	  et	  al.	  2008).	  	  
The	  mature	  sequences	  of	  miR-­‐H1	  and	  miR-­‐H6	  share	  significant	  sequence	  identity	  (Umbach	  et	  al.	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2008).	  	  Several	  of	  these	  miRNAs	  have	  functional	  implications	  due	  to	  seed	  sequence	  
complementarity	  with	  viral	  gene	  products.	  	  miR-­‐H2	  is	  transcribed	  in	  the	  antisense	  direction	  to	  
ICP0,	  and	  was	  found	  to	  repress	  its	  translation.	  	  miR-­‐H6	  is	  capable	  of	  repressing	  ICP4	  (Umbach	  et	  
al.	  2008).	  	  Both	  ICP0	  and	  ICP4	  are	  required	  for	  expression	  of	  viral	  gene	  products	  and	  are	  
suppressed	  during	  latency,	  suggesting	  a	  potential	  role	  for	  LAT-­‐encoded	  miRNAs	  in	  promoting	  
latency	  by	  suppressing	  factors	  required	  for	  reactivation.	  	  Recently,	  miR-­‐H1	  was	  found	  to	  repress	  
host	  cell	  protein	  ATRX	  during	  lytic	  infection,	  in	  cooperation	  with	  viral	  host-­‐cell	  shutoff	  protein	  
vhs.	  	  miR-­‐H1	  was	  able	  to	  repress	  a	  reporter	  containing	  only	  the	  3’	  UTR	  of	  ATRX,	  strongly	  
supporting	  evidence	  that	  miR-­‐H1	  is	  a	  functional	  miRNA	  during	  infection,	  acting	  through	  the	  
canonical	  mammalian	  RNA	  silencing	  pathway	  (Jurak	  et	  al.	  2012).	  
	   HSV-­‐1	  is	  fundamentally	  interconnected	  with	  the	  RNAi	  pathway	  due	  to	  both	  its	  
functionally	  expressed	  viral	  miRNAs	  and	  its	  newly	  demonstrated	  RSS	  activity.	  	  My	  study	  aimed	  to	  
characterize	  HSV-­‐1	  interaction	  with	  the	  endogenous	  miRNA	  pathway,	  including	  both	  its	  RNA	  and	  
protein	  components.	  	  In	  2009,	  Wu	  et	  al.	  suggested	  an	  interaction	  between	  HSV-­‐1	  and	  the	  RNAi	  
pathway	  by	  demonstrating	  that	  inhibition	  of	  ago2	  enhanced	  viral	  replication,	  and	  disrupted	  
exogenous	  RNA	  silencing.	  	  As	  a	  result	  of	  these	  findings,	  I	  decided	  to	  investigate	  potential	  
interactions	  of	  HSV-­‐1	  with	  the	  miRNA	  pathway,	  as	  miRNAs	  comprise	  most	  of	  the	  endogenous	  
small	  RNAs	  in	  mammals.	  	  Using	  a	  physiologically	  relevant	  keratinocyte	  in	  vitro	  culture	  system,	  I	  
assessed	  the	  result	  of	  suppression	  of	  RNAi	  pathway	  components	  on	  viral	  production,	  and	  
investigated	  the	  effects	  of	  HSV-­‐1	  infection	  on	  miRNA	  silencing	  and	  expression.	  	  In	  accordance	  
with	  the	  findings	  of	  Wu	  et	  al.	  in	  2009,	  we	  hypothesized	  that	  the	  endogenous	  RNAi	  pathway	  can	  
restrict	  HSV-­‐1	  infection	  in	  keratinocytes,	  and	  the	  virus	  counteracts	  this	  restriction	  by	  blocking	  
miRNA	  silencing.	  	  Our	  findings	  confirmed	  this	  hypothesis,	  and	  suggested	  ablation	  of	  mature	  
miRNA	  suppression	  as	  a	  potential	  mechanism	  for	  HSV-­‐1	  RSS	  activity.	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Transgenic	  mice:	  	  Mice	  expressing	  floxed	  alleles	  of	  ago2	  (ago2fl/fl)	  or	  DGCR8	  (DGCR8fl/fl)	  were	  
used	  to	  generate	  keratinocytes	  knocked	  out	  for	  Ago2	  or	  DGCR8,	  respectively.	  	  Ago2fl/fl	  mice	  were	  
obtained	  from	  A.	  Tarakhovsky	  (Rockefeller	  University).	  	  These	  animals	  were	  generated	  via	  
knock-­‐in	  insertion	  of	  LoxP	  sites	  flanking	  exons	  9-­‐11	  of	  the	  Eif2c2	  gene	  (ago2).	  	  Deletion	  of	  these	  
exons	  produces	  a	  non-­‐functional	  gene	  product	  by	  eliminating	  the	  mid	  domain	  of	  ago2,	  resulting	  
in	  loss	  of	  expression	  (O’Carroll	  et	  al.	  2007).	  	  Ago2fl/fl	  mice	  were	  generated	  on	  a	  C57BL/6	  
background,	  but	  were	  subsequently	  bred	  into	  a	  mixed	  background.	  	  DGCR8fl/fl	  animals	  were	  
created	  by	  inserting	  LoxP	  sites	  flanking	  exon	  3.	  	  Deletion	  of	  exon	  3	  results	  in	  a	  frame	  shift	  
mutation	  and	  a	  truncated,	  non-­‐functional	  protein	  product	  (Yi	  et	  al.	  2009).	  	  Wild-­‐type	  animals,	  
lacking	  LoxP	  sites,	  are	  denoted	  as	  Ago2+/+	  or	  DGCR8+/+.	  	  Ago2	  was	  deleted	  in	  ago2fl/fl	  cells	  by	  in	  
vitro	  cre	  delivery	  by	  a	  cre-­‐expressing	  adenovirus	  (Ad-­‐Cre-­‐GFP).	  	  The	  adenoviral	  vector	  contains	  
cre	  recombinase	  fused	  to	  GFP,	  as	  a	  marker	  of	  efficient	  transduction.	  	  To	  control	  for	  any	  potential	  
effects	  due	  to	  adenoviral	  infection,	  cells	  denoted	  as	  ago2	  WT	  were	  infected	  with	  a	  GFP-­‐only	  
expressing	  adenovirus	  (Ad-­‐GFP).	  	  Adenoviruses	  were	  obtained	  from	  the	  University	  of	  Iowa	  Gene	  
Transfer	  Vector	  Core.	  	  Mice	  expressing	  cre	  recombinase	  under	  the	  control	  of	  the	  keratin-­‐14	  
promoter	  were	  obtained	  from	  E.	  Fuchs	  (Rockefeller	  University).	  	  These	  animals	  were	  generated	  
by	  injection	  of	  k14-­‐driven	  cre	  into	  oocytes,	  followed	  by	  random	  genomic	  integration	  (Vasioukhin	  
et	  al.	  1999).	  	  Multiple	  founder	  lines	  were	  generated,	  and	  screened	  for	  potential	  phenotypes	  due	  
to	  insertional	  mutagenesis.	  	  DGCR8fl/+	  animals	  were	  mated	  with	  k14-­‐cre	  mice	  to	  generate	  
DGCR8fl/+	  k14-­‐cre	  progeny.	  	  These	  mice	  were	  heterozygous	  for	  functional	  DGCR8,	  but	  
maintained	  viability.	  	  DGCR8fl/+	  k14-­‐cre	  animals	  were	  subsequently	  bred	  with	  each	  other	  to	  
produce	  a	  distribution	  of	  animals	  with	  DGCR8+/+	  k14-­‐cre	  (WT),	  DGCR8fl/+	  k14-­‐cre	  (het),	  or	  
DGCR8fl/fl	  k14-­‐cre	  (KO)	  genotypes.	  	  DGCR8	  knockout	  animals	  are	  viable	  up	  to	  postnatal	  day	  6	  
(p6),	  allowing	  ample	  time	  for	  isolation	  of	  primary	  keratinocytes.	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Primary	  Keratinocyte	  Isolation	  and	  Culture:	  Primary	  keratinocytes	  were	  isolated	  from	  animals	  
sacrificed	  at	  postnatal	  day	  1	  (p1).	  	  Total	  back	  skin	  was	  harvested	  and	  placed	  on	  a	  dispase	  
enzyme	  solution	  overnight	  at	  4°C,	  to	  separate	  the	  epidermis	  from	  the	  dermis.	  	  The	  next	  day,	  the	  
epidermis	  was	  manually	  removed	  and	  placed	  in	  a	  0.5%	  trypsin	  solution	  for	  five	  minutes	  at	  37°C.	  	  
Trypsin	  digestion	  releases	  living	  basal	  and	  suprabasal	  keratinocytes	  from	  the	  dead	  stratum	  
corneal	  layers.	  	  Basal	  keratinocytes	  are	  the	  dominant	  population	  isolated	  by	  this	  method,	  and	  
are	  selected	  for	  in	  culture	  because	  of	  their	  proliferative	  potential.	  	  Trypsin	  digestion	  generates	  a	  
single-­‐cell	  suspension,	  which	  can	  subsequently	  be	  plated	  to	  give	  rise	  to	  an	  immortalized	  culture,	  
or	  be	  directly	  plated	  for	  primary	  cell	  analyses.	  	  Immortalized	  cultures	  were	  obtained	  by	  plating	  
primary	  keratinocytes	  onto	  a	  monolayer	  of	  murine	  fibroblast	  cells	  and	  cultured	  until	  
spontaneously	  immortalized	  colonies	  arose	  (MEKs).	  	  Keratinocytes	  were	  maintained	  in	  E	  
medium	  with	  0.05mM	  calcium.	  	  For	  primary	  cell	  assays,	  freshly	  isolated	  keratinocytes	  were	  
directly	  plated	  into	  culture	  dishes.	  	  Cells	  were	  grown	  in	  E	  medium	  supplemented	  with	  0.2mM	  
calcium	  for	  24	  hours	  post	  isolation,	  after	  which	  the	  calcium	  concentration	  was	  lowered	  to	  
0.05mM.	  
HSV-­‐1	  Plaque	  titer	  assay:	  Viral	  supernatant	  was	  collected	  and	  used	  to	  make	  serial	  tenfold	  
dilutions	  in	  phosphate-­‐buffered	  saline	  (PBS).	  	  Each	  dilution	  was	  used	  to	  infect	  one	  well	  of	  a	  
confluent	  monolayer	  (1	  million	  cells)	  of	  African	  Green	  Monkey	  kidney	  (Vero)	  cells	  in	  a	  six	  well	  
plate.	  	  Four	  hours	  post	  infection,	  medium	  was	  replaced	  with	  low-­‐serum	  DMEM	  (2%	  FBS)	  with	  
0.44%	  agarose	  and	  allowed	  to	  solidify	  at	  room	  temperature	  for	  five	  minutes.	  	  Plates	  were	  
incubated	  at	  37°C	  for	  two	  days,	  and	  then	  fixed	  overnight	  in	  4%	  PFA.	  	  Cells	  were	  stained	  with	  
0.2%	  crystal	  violet	  in	  70%	  ethanol	  to	  visualize	  plaque	  formation.	  	  Dilutions	  containing	  between	  
ten	  and	  one	  hundred	  plaques	  were	  used	  to	  calculate	  titer.	  	  The	  numbers	  of	  plaques	  were	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counted,	  multiplied	  by	  the	  dilution	  factor	  and	  the	  volume	  used	  to	  prepare	  the	  dilution.	  	  Titers	  
are	  reported	  in	  plaque	  forming	  units	  per	  milliliter	  (PFU/mL).	  
HSV-­‐1	  viral	  stocks:	  HSV-­‐1	  KOS	  strain	  was	  purchased	  from	  ATCC.	  	  Viruses	  were	  plaque-­‐purified	  to	  
isogenic	  stocks	  using	  the	  plaque	  assay	  technique	  described	  above.	  	  Individual	  plaques	  obtained	  
during	  the	  plaque	  assay	  were	  assumed	  to	  contain	  a	  clonal	  virus	  population	  derived	  from	  one	  
infectious	  unit.	  	  Three	  days	  post	  infection,	  in	  the	  absence	  of	  fixation,	  agarose	  above	  a	  single	  
plaque	  was	  removed	  and	  re-­‐suspended	  in	  PBS.	  	  This	  stock	  was	  expanded	  in	  Vero	  cells,	  and	  
purified	  through	  two	  additional	  plaque	  assays	  resulting	  in	  a	  total	  of	  three	  rounds	  of	  plaque	  
purification.	  	  Purified	  virus	  was	  then	  grown	  on	  a	  monolayer	  of	  Vero	  cells.	  	  Supernatant	  was	  
collected	  48	  hours	  post	  infection,	  at	  100%	  CPE	  (cytopathic	  effect).	  	  Supernatant	  was	  stored	  at	  -­‐
80°C	  for	  use	  in	  future	  experiments.	  	  Two	  distinct	  strains	  were	  isolated	  during	  this	  process:	  one	  
capable	  of	  forming	  syncytia	  (syn+)	  and	  one	  negative	  for	  syncytia	  formation	  (syn-­‐).	  	  Syn+	  virus	  
was	  selected	  for	  use	  in	  further	  experiments.	  	  UV-­‐inactivated	  HSV-­‐1	  was	  derived	  from	  plaque-­‐
purified	  syn+	  viral	  stocks,	  which	  were	  exposed	  to	  UV-­‐C	  light	  at	  a	  dosage	  of	  2.0	  mJ/cm2.	  
RNA	  extraction	  and	  q-­‐RT-­‐PCR:	  Total	  RNA	  was	  harvested	  from	  keratinocytes	  by	  Trizol®	  
extraction,	  followed	  by	  precipitation	  in	  100%	  isopropanol,	  and	  80%	  ethanol	  wash.	  	  RNA	  pellets	  
were	  dried	  in	  a	  37°C	  heat	  block	  for	  7	  min	  to	  remove	  residual	  ethanol.	  	  Dried	  RNA	  was	  dissolved	  
in	  RNase	  free	  DEPC-­‐treated	  water	  on	  ice	  for	  30	  min.	  	  RNA	  concentration	  was	  determined	  by	  
spectroscopy	  on	  a	  Nanodrop-­‐2000	  instrument.	  	  500ng	  of	  RNA	  was	  used	  in	  the	  reverse	  
transcriptase	  reaction	  (RT)	  to	  make	  cDNA	  libraries	  (miScript	  kit,	  Qiagen).	  	  The	  reaction	  was	  held	  
at	  37°C	  for	  60	  minutes,	  followed	  by	  a	  5	  minute	  denaturation	  at	  95°C.	  	  No-­‐RT	  (NRT)	  controls	  were	  
also	  generated	  from	  each	  RNA	  sample	  during	  the	  reverse	  transcription	  procedure,	  and	  were	  
used	  to	  evaluate	  possible	  DNA	  contamination	  during	  q-­‐RT-­‐PCR	  reactions.	  	  Quantitative	  PCR	  was	  
performed	  using	  the	  SYBR	  green	  master	  mix	  (Biorad),	  according	  to	  the	  manufacturer-­‐provided	  
METHODS	   	   	   	  25	  
instructions.	  	  10μL	  reactions	  were	  performed	  in	  384	  well	  plates,	  and	  SYBR	  green	  intensity	  was	  
measured	  using	  a	  Biorad	  CFX384	  1000	  series	  real-­‐time	  PCR	  machine.	  	  No-­‐RT	  and	  no-­‐template	  
(water)	  controls	  were	  run	  alongside	  all	  samples	  to	  assess	  any	  nucleic	  acid	  contamination.	  	  
miScript	  primers	  were	  used	  in	  conjunction	  with	  a	  proprietary	  universal	  primer	  for	  miRNA	  and	  
small	  RNA	  q-­‐RT-­‐PCR	  (Qiagen).	  	  Relative	  quantity	  and	  standard	  error	  of	  the	  mean	  (SEM)	  
calculations	  were	  performed	  with	  BioRad	  CFX	  software.	  
Western	  blotting:	  Protein	  lysates	  were	  prepared	  from	  cultured	  or	  primary	  keratinocytes.	  	  Cells	  
were	  removed	  from	  culture	  dishes	  by	  trypsinization	  for	  10	  minutes	  at	  37°C,	  followed	  by	  
quenching	  with	  an	  equal	  volume	  of	  E	  medium.	  	  Cells	  were	  then	  pelleted	  and	  washed	  in	  PBS.	  	  Cell	  
pellets	  were	  lysed	  in	  SET	  buffer	  (2%	  SDS,	  20mM	  Tris	  pH	  6.8,	  1mM	  EDTA	  pH	  8.0)	  and	  boiled	  for	  30	  
minutes.	  	  Total	  protein	  was	  quantified	  using	  a	  BCA	  assay	  (Pierce).	  	  20μg	  of	  protein	  was	  mixed	  
with	  Laemmli	  buffer	  (4%	  SDS,	  10%	  β-­‐mercaptoethanol,	  20%	  glycerol,	  0.02%	  bromophenol	  blue,	  
125mM	  Tris-­‐HCl)	  and	  loaded	  onto	  a	  10%	  acrylamide	  SDS-­‐PAGE	  gel.	  	  Fisher	  PagerulerPlus®	  
prestained	  protein	  ladder	  was	  loaded	  alongside	  samples	  to	  guide	  size	  determination.	  	  Following	  
electrophoresis,	  proteins	  were	  transferred	  onto	  PVDF	  membranes.	  	  The	  transfer	  was	  performed	  
at	  4°C	  and	  100V,	  for	  90	  minutes	  in	  a	  solution	  of	  20%	  methanol,	  25mM	  Tris-­‐base,	  and	  192mM	  
glycine.	  	  Following	  the	  transfer,	  membranes	  were	  blocked	  in	  a	  solution	  of	  5%	  milk	  in	  PBS-­‐T	  (1X	  
PBS	  plus	  0.2%	  tween-­‐20).	  	  Membranes	  were	  washed	  in	  PBS-­‐T	  three	  times	  for	  20	  minutes,	  and	  
placed	  in	  primary	  antibody	  overnight	  at	  4°C.	  	  The	  following	  antibodies	  were	  used:	  Ago2	  (1:5,000,	  
MBL	  RN029PW),	  β-­‐tubulin	  (1:5,000,	  Cell	  Signaling	  #2146S),	  DGCR8	  (1:1,000,	  Aviva	  Systems	  
Biology	  #ARP40984_P050).	  	  Membranes	  were	  washed	  again	  after	  primary	  antibody	  incubation	  
in	  PBS-­‐T	  three	  times	  for	  10	  minutes.	  	  HRP-­‐conjugated	  goat	  anti-­‐rabbit	  secondary	  antibody	  was	  
diluted	  1:20,000	  in	  5%	  milk	  in	  PBS-­‐T.	  	  Secondary	  antibody	  incubations	  were	  done	  for	  2	  hours	  at	  
room	  temperature.	  	  Membranes	  were	  then	  subjected	  to	  a	  final	  PBS-­‐T	  wash	  three	  times	  for	  20	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minutes.	  	  Blots	  were	  incubated	  in	  ECL	  prime	  chemiluminescent	  substrate	  (GE)	  for	  two	  minutes,	  
and	  then	  exposed	  to	  CL-­‐Xposure	  film	  (Kodak)	  for	  varying	  times.	  	  	  
Plasmid	  construction:	  	  Luciferase	  expression	  plasmid	  pGL3	  control	  was	  obtained	  from	  Promega.	  	  
It	  drives	  expression	  of	  firefly	  luciferase	  from	  an	  SV-­‐40	  promoter,	  and	  downstream	  enhancer.	  	  
Several	  cloning	  sites	  have	  been	  placed	  between	  the	  stop	  codon	  and	  poly-­‐A	  site,	  allowing	  
insertion	  of	  3’UTR	  elements	  or	  miRNA	  target	  sites.	  	  For	  miR-­‐203	  and	  miR-­‐205	  reporters,	  two	  
serial	  perfect	  match	  target	  sites	  were	  inserted	  into	  pGL3	  downstream	  of	  luciferase,	  separated	  by	  
spacer	  nucleotides	  (pGL3-­‐2x203,	  and	  pGL3-­‐2x205).	  	  Perfect	  match	  target	  sites	  bear	  100%	  
sequence	  complementarity	  to	  the	  full-­‐length	  mature	  miRNA,	  and	  catalyze	  cleavage	  of	  luciferase	  
mRNA	  and	  prevent	  translation.	  	  The	  miR-­‐200b	  reporter	  was	  constructed	  to	  contain	  two	  matches	  
to	  the	  2-­‐8	  seed	  region,	  separated	  by	  a	  spacer.	  	  These	  bulged	  target	  sites	  mediate	  cleavage-­‐
independent	  translational	  repression	  of	  luciferase.	  
Luciferase	  assays:	  Immortalized	  keratinocytes	  were	  plated	  in	  24-­‐well	  plate	  format,	  at	  a	  density	  
of	  50,000	  cells	  per	  well.	  	  24	  hours	  after	  plating,	  cells	  were	  transfected	  using	  the	  lipid-­‐based	  
reagent	  trans-­‐it	  LT-­‐1	  (mirus	  bio).	  	  The	  following	  concentrations	  were	  used	  (per	  well):	  50μL	  opti-­‐
MEM	  media,	  380ng	  MIGR-­‐GFP	  (fluorescence	  marker	  indicating	  successful	  transfection),	  20ng	  
firefly	  luciferase	  reporter	  (pGL3,	  2x203,	  2x205,	  or	  2x200b),	  2ng	  renilla	  luciferase,	  and	  1.5μL	  LT-­‐1.	  	  
Transfection	  mixes	  were	  incubated	  for	  20	  minutes	  at	  room	  temperature	  before	  being	  added	  
drop-­‐wise	  to	  cell	  cultures.	  	  All	  assays	  were	  designed	  in	  triplicate	  in	  24-­‐well	  plate	  format.	  	  At	  36	  
hours	  post-­‐transfection,	  cells	  were	  infected	  with	  wild	  type	  HSV-­‐1,	  or	  DMEM	  (noninfected	  
control)	  at	  an	  MOI	  of	  1	  PFU	  per	  cell.	  	  Cells	  were	  lysed	  directly	  in	  the	  plate	  with	  1x	  passive	  lysis	  
buffer	  in	  PBS	  (Promega)	  12	  hours	  post	  infection.	  	  The	  Dual	  Luciferase	  Assay	  kit	  (Promega)	  was	  
used	  to	  quantify	  luciferase	  levels.	  	  Each	  independent	  experiment	  was	  conducted	  in	  biological	  
triplicate,	  to	  account	  for	  inherent	  variation	  in	  the	  assay.	  	  Relative	  luciferase	  units	  were	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determined	  from	  the	  average	  of	  firefly:renilla	  (internal	  transfection	  control)	  ratios.	  	  Data	  was	  
then	  normalized	  within	  each	  reporter	  to	  noninfected	  controls,	  to	  visualize	  fold	  change	  among	  
reporters	  with	  varied	  baseline	  expression.	  	  Error	  was	  calculated	  from	  standard	  deviation	  of	  the	  
mean,	  and	  propagated	  across	  data	  normalization.	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Increased	  titers	  of	  HSV-­‐1	  are	  produced	  from	  keratinocytes	  in	  the	  absence	  of	  ago2.	  	  It	  was	  
previously	  reported	  that	  siRNA	  knockdown	  of	  ago2	  in	  293T	  cells	  produced	  four-­‐fold	  higher	  titers	  
of	  HSV-­‐1	  from	  those	  cells	  (Wu	  et	  al.	  2009).	  	  However,	  there	  are	  several	  caveats	  in	  this	  study.	  	  
Since	  ago2	  is	  a	  critical	  component	  of	  RISC,	  it	  is	  unable	  to	  be	  efficiently	  silenced	  with	  RNAi-­‐based	  
techniques.	  	  Additionally,	  293T	  (human	  embryonic	  kidney)	  cells	  are	  a	  poor	  model	  for	  lytic	  
infection,	  since	  productive	  replication	  of	  HSV-­‐1	  in	  vivo	  occurs	  in	  keratinocytes.	  	  Using	  a	  murine	  
genetic	  knockout	  system,	  I	  sought	  to	  test	  the	  effect	  of	  ago2	  on	  viral	  production	  in	  a	  
physiologically	  relevant	  keratinocyte	  culture	  system.	  	  Ago2	  was	  deleted	  in	  vitro	  from	  
immortalized	  murine	  keratinocytes	  derived	  from	  an	  ago2fl/fl	  mouse.	  	  Cre	  recombinase	  was	  
delivered	  to	  keratinocytes	  in	  an	  adenoviral	  vector,	  which	  also	  included	  a	  fluorescent	  GFP	  marker	  
fused	  to	  cre	  (Ad-­‐Cre-­‐GFP;	  ago2	  KO).	  	  As	  a	  control,	  ago2fl/fl	  cells	  were	  treated	  with	  a	  GFP-­‐only	  
expressing	  adenovirus	  (Ad-­‐GFP),	  to	  ensure	  that	  adenoviral	  infection	  had	  no	  effect	  on	  HSV-­‐1	  
production	  (ago2	  WT).	  	  Keratinocytes	  were	  infected	  with	  Ad-­‐Cre-­‐GFP	  or	  Ad-­‐GFP	  at	  an	  MOI	  of	  25,	  
which	  was	  the	  minimum	  required	  to	  efficiently	  deplete	  ago2	  protein	  (Figure	  3B).	  	  Four	  days	  after	  
adenoviral	  infection,	  ago2	  WT	  and	  ago2	  WT	  keratinocytes	  were	  infected	  with	  HSV-­‐1	  at	  MOI’s	  of	  
0.1	  and	  0.01.	  	  At	  the	  time	  of	  infection,	  protein	  lysate	  was	  collected	  to	  verify	  loss	  of	  ago2	  protein	  
by	  western	  blot	  (Figure	  3B).	  	  After	  36	  hours,	  virus-­‐containing	  supernatant	  was	  collected	  and	  titer	  
was	  determined	  by	  plaque	  assay	  on	  Vero	  cells.	  	  Keratinocytes	  lacking	  ago2	  produced	  six-­‐fold	  
higher	  titers	  of	  HSV-­‐1	  when	  infected	  at	  MOI=0.01,	  and	  two-­‐fold	  higher	  titers	  at	  MOI=0.1	  (Figure	  
3A).	  	  I	  hypothesized	  that	  infection	  at	  the	  higher	  MOI	  was	  successful	  in	  infecting	  the	  vast	  majority	  
of	  ago2	  WT	  and	  ago2	  WT	  cultures	  by	  36	  hours	  post	  infection	  and	  approaching	  saturated	  
conditions,	  thereby	  masking	  the	  effect	  of	  ago2	  loss-­‐of-­‐function	  on	  HSV-­‐1	  production.	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HSV-­‐1-­‐mediated	  cytopathic	  effect	  is	  accelerated	  in	  keratinocytes	  deficient	  for	  ago2.	  	  After	  
observing	  increased	  viral	  titers	  in	  the	  absence	  of	  ago2,	  I	  hypothesized	  that	  ago2	  KO	  cells	  had	  lost	  
a	  form	  of	  viral	  restriction.	  	  Certain	  strains	  of	  HSV-­‐1	  form	  large,	  multicellular	  fusions	  in	  vitro,	  
called	  syncytia.	  	  It	  is	  unknown	  why	  some	  viruses	  form	  syncytia,	  but	  it	  is	  thought	  to	  be	  mediated	  
by	  viral	  membrane	  fusion	  protein	  gD.	  	  The	  particular	  sub-­‐strain	  of	  HSV-­‐1	  KOS	  we	  have	  purified	  is	  
capable	  of	  syncytia	  formation	  in	  keratinocytes	  and	  Vero	  cells,	  and	  serves	  as	  an	  easily	  
distinguishable	  mark	  of	  cytopathic	  effect	  (CPE).	  	  To	  determine	  if	  ago2	  KO	  cells	  were	  less	  able	  to	  
control	  HSV-­‐1	  replication	  than	  their	  wild-­‐type	  counterparts,	  we	  infected	  keratinocytes	  with	  HSV-­‐
1	  at	  an	  MOI	  of	  0.01.	  	  At	  24	  hours	  post-­‐infection,	  visible	  cytopathic	  effect	  was	  assessed	  in	  each	  
population.	  	  Ago2	  WT	  cultures	  showed	  little,	  if	  any,	  signs	  of	  viral	  CPE.	  	  Ago2	  KO	  cells,	  
	  
Figure	  3.	  Higher	  titers	  of	  virus	  are	  produced	  from	  keratinocytes	  in	  the	  absence	  of	  Ago2.	  	  (A)	  
Spontaneously	  immortalized	  keratinocytes	  derived	  from	  ago2fl/fl	  mice	  propagated	  in	  culture.	  	  Ago2	  
was	  deleted	  using	  cre	  recombinase,	  delivered	  by	  an	  adenoviral	  vector	  (Ad-­‐Cre-­‐GFP).	  	  Ago2fl/fl	  cells	  
were	  also	  infected	  with	  a	  control	  adenovirus	  expressing	  only	  GFP	  (Ad-­‐GFP),	  to	  control	  for	  any	  effects	  
of	  adenovirus	  infection.	  	  Four	  days	  after	  ago2	  deletion,	  cells	  were	  infected	  with	  HSV-­‐1,	  at	  MOI’s	  of	  0.1	  
or	  0.01.	  	  Virus-­‐containing	  culture	  supernatant	  was	  collected	  36	  hours	  post	  infection.	  	  Titer	  was	  
determined	  by	  plaque	  assay	  on	  Vero	  cells.	  	  Error	  bars	  represent	  standard	  deviation	  between	  technical	  
duplicate	  plaque	  assays.	  	  Data	  is	  representative	  of	  n=2	  independent	  experiments.	  	  (B)	  To	  verify	  
efficient	  loss	  of	  ago2	  following	  cre-­‐mediated	  deletion,	  protein	  lysates	  were	  collected	  and	  ago2	  protein	  
expression	  was	  determined	  by	  western	  blot.	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however,	  had	  numerous	  clearly	  formed	  syncytia	  and	  substantially	  more	  cell	  death	  (Figure	  3).	  	  
Uninfected	  cells	  displayed	  no	  difference	  in	  viability	  after	  loss	  of	  ago2.	  
HSV-­‐1	  relieves	  endogenous	  miRNA	  silencing.	  	  In	  2009,	  Wu	  and	  colleagues	  reported	  that	  HSV-­‐1	  
infection	  suppressed	  exogenous	  shRNA-­‐mediated	  silencing	  of	  a	  GFP	  reporter	  (Wu	  et	  al.	  2009).	  	  A	  
mechanism	  for	  this	  RSS	  activity	  was	  not	  discussed.	  	  To	  explore	  this	  effect	  further,	  I	  decided	  to	  
determine	  if	  HSV-­‐1	  infection	  could	  suppress	  silencing	  by	  endogenous	  miRNAs.	  	  Using	  a	  luciferase	  
assay	  system,	  firefly	  luciferase	  reporter	  constructs	  were	  designed	  to	  contain	  target	  sites	  for	  
several	  miRNAs	  that	  are	  highly	  expressed	  in	  the	  skin.	  	  I	  selected	  miR-­‐203,	  miR-­‐205,	  and	  miR-­‐
200b.	  	  miR-­‐203,	  miR-­‐205,	  and	  miR-­‐200b	  represent	  24%,	  12%,	  and	  2%	  of	  all	  miRNAs	  present	  in	  
the	  skin,	  respectively	  (Zhang	  et	  al.,	  unpublished	  data).	  	  The	  pGL3	  control	  vector	  was	  used	  as	  the	  
backbone	  for	  construction	  of	  reporters,	  and	  was	  also	  used	  as	  an	  experimental	  control.	  	  pGL3	  
	  
Figure	  4.	  Loss	  of	  Ago2	  results	  in	  accelerated	  cytopathic	  effect	  during	  HSV-­‐1	  infection.	  	  Ago2fl/fl	  cells	  
were	  infected	  with	  Ad-­‐Cre-­‐GFP	  or	  Ad-­‐GFP	  (control)	  to	  delete	  ago2.	  	  Four	  days	  post	  deletion,	  ago2	  
WT	  and	  ago2	  KO	  were	  infected	  with	  HSV-­‐1	  at	  an	  MOI	  of	  0.01.	  	  24	  hours	  post	  infection,	  keratinocytes	  
were	  visualized	  by	  brightfield	  microscopy.	  	  Large,	  multi-­‐cellular	  fusions	  known	  as	  syncytia	  were	  used	  
as	  markers	  of	  cytopathic	  effect.	  	  Noninfected	  keratinocytes	  were	  imaged	  as	  controls;	  loss	  of	  ago2	  
had	  no	  effect	  on	  viability	  of	  noninfected	  cells.	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control	  expresses	  firefly	  luciferase	  in	  mammalian	  cells,	  driven	  from	  an	  SV-­‐40	  promoter.	  	  It	  also	  
contains	  an	  SV-­‐40	  poly-­‐A	  site	  and	  enhancer	  element	  downstream	  of	  luciferase.	  	  Two	  perfect-­‐
match	  (miR-­‐203,	  miR-­‐205)	  or	  bulged	  (miR-­‐200b)	  were	  inserted	  into	  the	  pGL3	  control	  vector,	  in	  
the	  3’	  UTR	  region	  of	  luciferase	  (2x203,	  2x205,	  2x200b).	  	  This	  results	  in	  miRNA-­‐specific	  repression	  
of	  luciferase	  by	  these	  miRNAs.	  	  Immortalized	  MEKs	  were	  transiently	  transfected	  with	  pGL3	  
control,	  2x203,	  2x205,	  or	  2x200b.	  	  Renilla	  luciferase	  was	  co-­‐transfected	  along	  with	  each	  firefly	  
reporter,	  as	  a	  control	  for	  transfection	  efficiency.	  	  36	  hours	  post	  transfection,	  keratinocytes	  were	  
infected	  with	  HSV-­‐1	  at	  MOI=1,	  or	  noninfected	  (media)	  control.	  	  Infection	  progressed	  for	  12	  
hours,	  allowing	  expression	  of	  all	  α,	  β,	  and	  γ	  genes.	  	  Cells	  were	  then	  lysed,	  and	  firefly	  and	  renilla	  
luminescence	  was	  quantified	  using	  the	  Promega	  Dual	  Luciferase	  Assay.	  	  As	  expected,	  the	  
addition	  of	  miRNA	  target	  sites	  to	  the	  3’	  UTR	  of	  pGL3	  luciferase	  greatly	  reduced	  reporter	  
expression	  in	  cells	  expressing	  those	  miRNAs,	  compared	  to	  pGL3	  control	  (Figure	  5A).	  	  	  
	  
Figure	  5.	  	  HSV-­‐1	  infection	  blocks	  endogenous	  
miRNA	  silencing	  in	  keratinocytes.	  	  (A)	  Wild-­‐
type	  MEKs	  were	  transfected	  with	  pGL3,	  
2x200b,	  2x203,	  or	  2x205.	  	  Firefly	  luminescence	  
was	  quantified	  and	  normalized	  to	  renilla	  to	  
determine	  miRNA-­‐mediated	  repression	  of	  
reporters.	  (B)	  Wild-­‐type	  MEKs	  were	  
transfected	  with	  pGL3,	  or	  reporters	  for	  miRNA	  
activity	  (2x200b,	  2x203,	  or	  2x205)	  and	  renilla	  
luciferase	  (internal	  transfection	  control).	  	  36	  
hours	  post-­‐transfection,	  keratinocytes	  were	  
infected	  for	  12	  hours	  with	  HSV-­‐1	  (MOI=1)	  or	  
media	  control.	  Luminescence	  of	  firefly	  
luciferase	  was	  quantified	  to	  determine	  
reporter	  expression,	  and	  normalized	  to	  renilla.	  
To	  correct	  for	  variable	  baseline	  expression	  
among	  the	  different	  reporter	  constructs,	  each	  
reporter	  was	  normalized	  to	  reflect	  de-­‐
repression	  relative	  to	  the	  noninfected	  
condition.	  	  Error	  bars	  represent	  standard	  
deviation	  of	  three	  technical	  replicates.	  	  Data	  is	  
representative	  of	  n=2	  independent	  
experiments.	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However,	  in	  HSV-­‐1	  infected	  cells,	  miRNA	  target	  sites	  had	  no	  repressive	  effects	  compared	  to	  
noninfected	  controls,	  and	  reporter	  expression	  was	  elevated	  up	  to	  two-­‐fold	  above	  pGL3	  control	  
levels	  (Figure	  5B).	  
HSV-­‐1	  infection	  abolishes	  expression	  of	  mature	  host	  miRNAs.	  	  After	  observing	  HSV-­‐1-­‐mediated	  
suppression	  of	  endogenous	  miRNA	  silencing,	  I	  sought	  to	  investigate	  the	  mechanism.	  	  I	  
hypothesized	  that	  HSV-­‐1	  could	  either	  prevent	  expression	  of	  mature	  miRNAs,	  blocking	  their	  
ability	  to	  silence	  targets,	  or	  disrupt	  the	  formation	  or	  action	  of	  RISC.	  	  To	  determine	  if	  miRNA	  
expression	  was	  disrupted	  by	  HSV-­‐1,	  I	  examined	  levels	  of	  mature	  miRNA	  transcripts	  by	  
quantitative	  real-­‐time	  PCR	  in	  keratinocytes	  infected	  with	  HSV-­‐1	  or	  media	  control.	  	  MEKs	  were	  
infected	  with	  HSV-­‐1	  at	  an	  MOI	  of	  1.	  	  After	  12	  hours,	  cells	  were	  lysed	  and	  total	  RNA	  was	  
extracted.	  	  cDNA	  libraries	  were	  generated	  by	  reverse	  transcription,	  and	  used	  in	  q-­‐RT-­‐PCR	  
reactions	  to	  compare	  levels	  of	  miR-­‐200b,	  miR-­‐203,	  and	  miR-­‐205	  between	  infected	  and	  
noninfected	  samples.	  	  Small	  nuclear	  and	  small	  nucleolar	  RNAs	  were	  used	  as	  controls,	  since	  they	  
	  
Figure	  6.	  HSV-­‐1	  infection	  causes	  dramatic	  loss	  of	  mature	  miRNAs.	  	  MEKs	  were	  infected	  with	  HSV-­‐1	  for	  
twelve	  hours	  (MOI=1).	  	  Total	  RNA	  was	  harvested	  via	  Trizol®	  extraction,	  and	  converted	  to	  cDNA	  by	  reverse	  
transcription.	  	  cDNA	  libraries	  were	  used	  in	  q-­‐RT-­‐PCR	  reactions	  to	  detect	  mature	  miRNAs	  and	  control	  small	  
RNAs	  with	  the	  Qiagen	  miScript	  system.	  	  Ribosomal,	  small	  nucleolar,	  and	  small	  nuclear	  RNAs	  were	  used	  as	  
controls,	  as	  they	  had	  been	  previously	  shown	  to	  be	  unchanged	  during	  HSV-­‐1	  infection.	  	  Data	  shown	  is	  
relative	  quantity	  (ΔCq),	  without	  normalization	  to	  housekeeping	  genes.	  	  Within	  each	  primer	  set,	  relative	  
quantity	  was	  normalized	  to	  the	  noninfected	  sample.	  	  Error	  bars	  represent	  standard	  error	  of	  the	  mean,	  
from	  technical	  duplicates.	  	  Data	  is	  representative	  to	  n=2	  independent	  experiments.	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are	  unaffected	  by	  HSV-­‐1	  infection.	  	  HSV-­‐1	  infection	  resulted	  in	  dramatic	  loss	  of	  mature	  miRNA	  
expression.	  	  miR-­‐200b,	  miR-­‐203,	  and	  miR-­‐205	  were	  reduced	  to	  0.74%,	  8.44%,	  and	  0.51%	  of	  
noninfected	  levels,	  respectively	  (Figure	  6).	  
HSV-­‐1	  does	  not	  disrupt	  expression	  of	  ago2.	  	  In	  order	  to	  uncover	  a	  potential	  mechanism	  for	  	  
HSV-­‐1	  suppression	  of	  mature	  miRNA	  expression	  and	  activity,	  I	  probed	  infected	  cell	  lysates	  for	  
expression	  of	  various	  miRNA	  pathway	  components.	  	  Our	  laboratory	  has	  previously	  observed	  
that	  loss	  of	  argonaute	  family	  members	  can	  result	  in	  mild	  loss	  of	  mature	  miRNAs.	  	  This	  
observation,	  combined	  with	  the	  finding	  that	  HSV-­‐1	  titers	  are	  enhanced	  in	  the	  absence	  of	  ago2,	  
potentially	  implicates	  ago2	  as	  a	  part	  of	  a	  host	  restriction	  that	  the	  virus	  must	  overcome.	  	  To	  
determine	  if	  HSV-­‐1	  suppresses	  ago2	  expression,	  I	  analyzed	  protein	  lysates	  of	  infected	  cells	  by	  
western	  blot.	  	  MEKs	  were	  infected	  with	  wild-­‐type	  or	  UV-­‐inactivated	  HSV-­‐1	  for	  6	  or	  12	  hours,	  at	  
which	  total	  protein	  lysate	  was	  collected.	  	  Protein	  concentration	  was	  determined	  and	  
standardized	  by	  BCA	  assay	  before	  SDS-­‐PAGE	  analysis.	  	  Lysates	  were	  probed	  for	  ago2,	  along	  with	  
β-­‐tubulin,	  which	  is	  unchanged	  during	  HSV-­‐1	  infection.	  	  No	  change	  in	  ago2	  expression	  occurred	  
during	  wild-­‐type	  or	  UV-­‐inactivated	  infection	  at	  any	  time	  point,	  suggesting	  that	  HSV-­‐1	  blocks	  
miRNA	  expression	  and	  function	  independently	  of	  ago2	  and	  RISC	  (Figure	  7).	  
	  
Figure	  7.	  HSV-­‐1	  infection	  does	  not	  perturb	  expression	  of	  Ago2.	  	  MEKs	  were	  infected	  with	  wild-­‐type	  or	  
UV-­‐inactivated	  HSV-­‐1	  at	  an	  MOI	  of	  3.	  	  Protein	  lysate	  was	  harvested	  at	  6	  and	  12	  hours	  post	  infection,	  
and	  quantified	  by	  BCA	  assay.	  	  Total	  protein	  (20ug)	  was	  run	  on	  an	  SDS-­‐PAGE	  gel,	  transferred	  to	  PVDF	  
membrane,	  and	  probed	  for	  Ago2	  and	  β-­‐tubulin	  (control).	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In	  2009,	  Wu	  and	  colleagues	  observed	  an	  interaction	  between	  HSV-­‐1	  and	  the	  RNA	  
silencing	  pathway	  in	  mammalian	  cell	  culture.	  	  This	  was	  a	  particularly	  significant	  finding,	  as	  it	  is	  
one	  of	  the	  first	  demonstrations	  of	  a	  potential	  antiviral	  RNAi	  mechanism	  in	  mammals.	  	  
Previously,	  studies	  of	  antiviral	  RNAi	  activity	  had	  been	  restricted	  to	  plant	  and	  insect	  infection	  by	  
RNA	  viruses.	  	  The	  2009	  study	  by	  Wu	  et	  al.	  broke	  both	  of	  these	  barriers,	  in	  that	  their	  analysis	  was	  
conducted	  in	  a	  mammalian	  system	  in	  the	  context	  of	  a	  double-­‐stranded	  DNA	  virus	  infection.	  	  
They	  demonstrated	  that	  HSV-­‐1	  is	  capable	  of	  RSS	  activity,	  through	  the	  observation	  that	  HSV-­‐1	  
infection	  blocked	  shRNA-­‐mediated	  silencing	  of	  a	  GFP	  reporter.	  	  Additionally,	  they	  showed	  that	  
siRNA	  knockdown	  of	  ago2	  enhanced	  viral	  replication	  in	  HEK	  293T	  cells	  (Wu	  et	  al.	  2009).	  	  Despite	  
their	  novel	  finding,	  there	  are	  several	  critical	  caveats	  to	  their	  study.	  	  Wu	  et	  al.	  carried	  out	  
experiments	  in	  an	  exogenous,	  non-­‐physiologically	  relevant	  system,	  and	  failed	  to	  suggest	  a	  
mechanism.	  	  I	  chose	  to	  explore	  these	  findings	  further,	  by	  investigating	  HSV-­‐1	  interaction	  with	  
the	  endogenous	  RNA	  silencing	  pathway	  in	  keratinocytes,	  the	  virus’	  natural	  host	  during	  lytic	  
infection.	  	  Using	  a	  mouse	  knockout	  model	  in	  vitro,	  I	  validated	  the	  finding	  that	  ago2	  loss-­‐of-­‐
function	  in	  the	  producer	  cell	  enhances	  viral	  titers	  (Figure	  3A).	  	  This	  result	  lead	  me	  to	  the	  
hypothesis	  that	  ago2	  is	  acting	  as	  a	  host	  restriction	  factor,	  or	  through	  an	  inhibitory	  mechanism,	  
to	  limit	  HSV-­‐1	  replication	  in	  keratinocytes.	  	  Since	  ago2	  is	  a	  critical	  component	  of	  the	  mammalian	  
endogenous	  RNAi	  pathway,	  it	  is	  likely	  that	  ago2	  restricts	  the	  virus	  through	  the	  activity	  of	  small	  
RNAs.	  	  I	  focused	  my	  efforts	  on	  the	  miRNA	  pathway,	  since	  miRNAs	  are	  the	  most	  abundant	  small	  
interfering	  RNAs	  in	  mammals.	  	  Additionally,	  it	  is	  unlikely	  that	  ago2	  restricts	  HSV-­‐1	  replication	  in	  
a	  manner	  similar	  to	  that	  suggested	  by	  van	  Rij	  et	  al.,	  and	  Wang	  et	  al.	  (2006).	  	  Both	  groups	  
observed	  synergistic	  action	  between	  dicer-­‐2	  and	  Ago-­‐2	  that	  produced	  perfectly	  complementary	  
siRNAs	  from	  viral	  RNA	  genomes	  in	  drosophila.	  	  However,	  since	  HSV-­‐1	  is	  a	  dsDNA	  virus	  and	  does	  
not	  go	  though	  a	  dsRNA	  intermediate	  stage	  that	  could	  be	  recognized	  by	  dicer,	  it	  is	  more	  likely	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that	  mammalian	  ago2	  is	  acting	  in	  concert	  with	  endogenous	  small	  RNAs.	  	  My	  finding	  that	  HSV-­‐1	  
infection	  disrupts	  endogenous	  miRNA	  silencing	  supports	  this	  hypothesis	  (Figure	  5b).	  	  It	  is	  
interesting	  to	  note	  that	  HSV-­‐1	  infection	  suppressed	  siRNA	  and	  miRNA-­‐type	  targeting.	  	  miR-­‐203	  
and	  miR-­‐205	  reporters	  were	  constructed	  to	  contain	  target	  sites	  perfectly	  complementary	  to	  the	  
full-­‐length	  miRNA.	  	  This	  is	  typical	  of	  siRNA-­‐mediated	  silencing,	  and	  triggers	  cleavage	  of	  the	  
luciferase	  mRNA.	  	  mRNA	  cleavage	  is	  catalyzed	  by	  ago2	  slicer	  activity,	  and	  requires	  an	  enzymatic	  
domain	  that	  is	  only	  active	  in	  ago2.	  	  The	  miR-­‐200b	  reporter,	  however,	  contains	  mismatches	  
within	  the	  target	  sites,	  and	  is	  representative	  of	  miRNA-­‐mediated	  suppression.	  	  mRNA	  cleavage	  
should	  not	  occur	  in	  this	  instance,	  and	  translational	  repression	  is	  independent	  of	  ago2	  catalytic	  
activity.	  	  While	  my	  observation	  of	  HSV-­‐1	  suppression	  of	  RNA	  silencing	  corroborates	  that	  of	  Wu	  
et	  al.,	  I	  provide	  additional	  evidence	  that	  this	  phenomenon	  occurs	  in	  keratinocytes,	  and	  can	  
modulate	  the	  endogenous	  miRNA	  pathway.	  
There	  are	  several	  possible	  mechanisms	  for	  HSV-­‐1	  suppression	  of	  RNA	  silencing.	  	  After	  
observing	  that	  HSV-­‐1	  disrupts	  endogenous	  miRNA-­‐mediated	  silencing	  of	  luciferase	  reporters,	  I	  
considered	  that	  the	  virus	  could	  either	  disrupt	  the	  activity	  of	  RISC,	  or	  prevent	  expression	  of	  
mature	  miRNAs.	  	  My	  observation	  that	  mature	  miRNAs	  are	  significantly	  downregulated	  during	  
HSV-­‐1	  infection	  suggests	  the	  latter	  (Figure	  6).	  	  I	  first	  considered	  the	  virus-­‐encoded	  RNase	  vhs,	  
that	  is	  responsible	  for	  the	  characteristic	  host	  cell	  shutoff	  observed	  during	  infection.	  	  Vhs	  is	  
encoded	  by	  the	  viral	  UL-­‐41	  gene.	  	  Vhs	  is	  transcribed	  in	  the	  γ	  (late)	  set	  of	  gene	  products,	  but	  is	  
packaged	  into	  the	  virion	  tegument	  allowing	  it	  to	  act	  early	  in	  the	  viral	  life	  cycle.	  	  Vhs	  possesses	  
RNase	  activity	  similar	  to	  RNase	  A,	  and	  acts	  to	  degrade	  host	  mRNAs.	  	  Vhs	  is	  capable	  of	  
suppressing	  highly	  abundant	  mRNAs,	  including	  actin	  and	  GAPDH	  (Strelow	  et	  al.	  1995).	  	  Vhs-­‐
mediated	  RNA	  degradation	  is	  thought	  to	  be	  restricted	  to	  mRNAs,	  as	  no	  small	  nuclear	  RNA	  
degradation	  has	  been	  observed,	  and	  it	  is	  theorized	  that	  vhs	  recognizes	  the	  5’	  cap	  of	  mRNAs.	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However,	  it	  is	  entirely	  plausible	  that	  vhs	  can	  degrade	  miRNAs,	  either	  as	  intermediates	  in	  the	  
biogenesis	  pathway	  or	  in	  their	  mature	  form.	  	  Vhs-­‐mediated	  degradation	  could	  be	  responsible	  for	  
the	  observed	  loss	  of	  mature	  miRNA	  during	  infection,	  and	  subsequent	  blockade	  of	  miRNA	  
silencing.	  	  However,	  Wu	  et	  al.	  showed	  that	  a	  vhs-­‐null	  virus	  was	  equally	  capable	  of	  RSS	  activity,	  
suggesting	  that	  vhs	  does	  not	  function	  in	  that	  mechanism.	  	  Although,	  loss	  of	  miRNA	  expression	  
could	  be	  distinct	  from	  HSV-­‐1	  RSS	  activity,	  and	  a	  vhs-­‐null	  virus	  should	  be	  used	  to	  determine	  if	  vhs	  
is	  involved	  in	  miRNA	  degradation.	  	  Loss	  of	  mature	  miRNA	  could	  also	  result	  from	  events	  other	  
than	  RNA	  degradation.	  	  miRNAs	  and	  shRNA-­‐derived	  siRNAs	  are	  produced	  through	  a	  well-­‐
characterized	  biogenesis	  pathway.	  	  Mouse	  knockout	  models	  have	  demonstrated	  that	  in	  the	  
absence	  of	  miRNA	  processing	  enzymes,	  miRNA	  expression	  is	  lost	  and	  severe	  defects	  in	  
development	  and	  tumorigenesis	  occur.	  	  By	  disrupting	  or	  degrading	  an	  essential	  component	  of	  
the	  miRNA	  biogenesis	  pathway,	  HSV-­‐1	  could	  efficiently	  prevent	  expression	  of	  endogenous	  
miRNAs.	  	  HSV-­‐1	  encodes	  a	  RING	  finger	  E3	  ubiquitin	  ligase,	  ICP0,	  which	  is	  capable	  of	  catalyzing	  
poly-­‐ubiquitination	  of	  cellular	  targets	  (Boutell	  et	  al.	  2013).	  	  It	  is	  possible	  that	  HSV-­‐1	  represses,	  
perhaps	  through	  degradation	  by	  ICP0,	  an	  essential	  miRNA	  biogenesis	  component.	  	  While	  I	  did	  
not	  observe	  loss	  of	  Ago2	  expression	  during	  infection,	  other	  components	  of	  the	  miRNA	  
biogenesis	  pathway	  remain	  to	  be	  tested	  (Figure	  7).	  
RNAi	  has	  been	  demonstrated	  as	  an	  essential	  antiviral	  mechanism	  for	  RNA	  viruses	  in	  
both	  plants	  and	  insects.	  	  Despite	  lacking	  analogs	  of	  the	  powerful	  mammalian	  adaptive	  immune	  
systems,	  plants	  and	  insects	  are	  able	  to	  effectively	  combat	  viral	  infections.	  	  Much	  of	  the	  
pioneering	  work	  in	  the	  anti-­‐viral	  RNAi	  field	  has	  been	  carried	  out	  in	  drosophila.	  	  Dicer-­‐2,	  in	  
collaboration	  with	  Ago-­‐2,	  cleaves	  dsRNA	  viral	  genomes	  into	  siRNAs,	  which	  are	  incorporated	  into	  
RISC	  and	  guide	  targeted,	  efficient	  degradation	  of	  viral	  genetic	  material.	  	  Since	  these	  small	  RNAs	  
are	  perfectly	  complementary	  to	  the	  viral	  genome,	  they	  direct	  RISC	  to	  cleave	  viral	  RNAs,	  which	  is	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characteristic	  of	  siRNA-­‐type	  silencing.	  	  Endogenous	  small	  RNAs	  have	  not	  yet	  been	  implicated	  in	  
the	  antiviral	  response.	  	  Both	  double	  and	  single-­‐stranded	  RNA	  viruses	  can	  fall	  victim	  to	  RNAi-­‐
mediated	  restriction,	  as	  many	  ssRNA	  viruses	  must	  undergo	  a	  dsRNA	  replication	  intermediate.	  	  
To	  date,	  observations	  of	  antiviral	  RNAi	  activity	  have	  mostly	  taken	  place	  in	  plants	  or	  insects	  
infected	  with	  RNA	  viruses.	  	  However,	  recent	  investigations	  of	  viral	  gene	  product	  function	  
suggest	  that	  anti-­‐viral	  RNAi	  mechanisms	  are	  somewhat	  conserved	  in	  mammals.	  	  Many	  viruses	  
have	  been	  found	  to	  encode	  gene	  products	  that	  have	  RSS	  functions.	  	  For	  example,	  HIV-­‐1	  
transcriptional	  activator	  protein	  (tat),	  is	  a	  potent	  suppressor	  of	  RNA	  silencing	  (Qian	  et	  al.	  2009).	  	  
Inhibition	  of	  RNAi	  machinery,	  by	  a	  multitude	  of	  methods,	  enhances	  HIV-­‐1	  transcription	  and	  
replication	  (Bennasser	  et	  al.	  2005;	  Qian	  et	  al.	  2009).	  	  Ebola	  virus	  also	  encodes	  a	  protein	  with	  RSS	  
function,	  VP35	  (Haasnoot	  et	  al.	  2007).	  	  VP35	  can	  rescue	  tat-­‐deficient	  HIV-­‐1	  viruses,	  suggesting	  
RSS	  function	  is	  conserved	  and	  critical	  among	  mammalian	  RNA	  viruses.	  	  The	  broad	  presence	  of	  
mammalian	  viral	  RSS	  proteins,	  combined	  with	  the	  observation	  that	  inhibition	  of	  RNAi	  machinery	  
enhances	  viral	  replication,	  strongly	  suggests	  that	  RNAi	  plays	  an	  antiviral	  role	  in	  mammals.	  	  Wu	  et	  
al.	  significantly	  broadened	  the	  understanding	  of	  mammalian	  anti-­‐viral	  RNAi	  by	  demonstrating	  
that	  HSV-­‐1,	  a	  dsDNA	  virus,	  also	  possesses	  RSS	  activity	  (Wu	  et	  al.	  2006).	  	  I	  expanded	  upon	  their	  
findings	  further	  by	  demonstrating	  that	  HSV-­‐1	  suppresses	  expression	  and	  function	  of	  
endogenous	  small	  RNAs,	  which	  has	  yet	  to	  be	  demonstrated	  in	  any	  viral	  system.	  	  The	  culmination	  
of	  evidence	  implicating	  the	  RNAi	  pathway	  in	  mammalian	  antiviral	  defense	  has	  opened	  
tremendous	  avenues	  for	  further	  research,	  particularly	  into	  the	  involvement	  of	  endogenous	  
small	  RNAs.	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   My	  study	  corroborates	  and	  expands	  upon	  the	  findings	  of	  Wu	  and	  colleagues,	  
demonstrating	  critical	  HSV-­‐1	  interactions	  with	  the	  RNA	  silencing	  pathway.	  	  Through	  ago2	  loss-­‐
of-­‐function	  studies,	  I	  have	  implicated	  the	  host	  RNAi	  pathway	  as	  a	  restriction	  factor	  for	  HSV-­‐1.	  	  I	  
also	  provide	  the	  first	  evidence	  of	  viral	  suppression	  of	  endogenous	  miRNAs,	  at	  both	  the	  levels	  of	  
function	  and	  expression.	  	  While	  a	  mechanism	  remains	  unknown,	  examination	  of	  miRNA	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